{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T14:05:45Z","timestamp":1792332345721,"version":"4.4.0"},"reference-count":257,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cholesterol metabolites are abundant in the central nervous system (CNS) that regulate cell membrane fluidity, signal transduction, and inter- and intracellular vesicular transport, as well as cell proliferation\/cell death or migration. Brain cholesterol synthesis and metabolism are tightly coupled to the functional homeostasis of neurons, glial cells or microglia, and dysregulation of these processes has been strongly implicated in neurodegenerative diseases such as Alzheimer\u2019s disease (AD), Parkinson\u2019s disease (PD), and Huntington\u2019s disease (HD). This review provides a comprehensive overview of how cholesterol synthesis, esterification, efflux, uptake, and oxidation affect the CNS function, highlighting the function of key enzymes or metabolites in distinct brain cell types during neurodegeneration. Based on single-cell\/nucleus RNA sequencing data from the brains of AD, PD, and HD patients, we summarize cell-type-specific genes in cholesterol metabolism pathways, shedding new light to understand cellular heterogeneity. The role of cholesterol-derived neurosteroids in neurodegenerative diseases is also discussed. Furthermore, how cholesterol metabolites modulate the formation, aggregation, and degradation of amyloid-\u03b2 (A\u03b2), \u03b1-synuclein and huntingtin, as well as Tau protein phosphorylation are outlined. Finally, future research directions are proposed that aim to understand neurodegenerative diseases with new angle.<\/jats:p>","DOI":"10.1186\/s13024-026-00951-3","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T02:55:16Z","timestamp":1779936916000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cholesterol metabolism in neurodegenerative diseases: mechanisms and therapeutic advances"],"prefix":"10.1186","volume":"21","author":[{"given":"Dezhen","family":"Tu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangyang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"issue":"4","key":"951_CR1","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s13238-014-0131-3","volume":"6","author":"J Zhang","year":"2015","unstructured":"Zhang J, Liu Q. Cholesterol metabolism and homeostasis in the brain. Protein Cell. 2015;6(4):254\u201364. https:\/\/doi.org\/10.1007\/s13238-014-0131-3.","journal-title":"Protein Cell"},{"issue":"4","key":"951_CR2","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.plipres.2011.06.002","volume":"50","author":"FW Pfrieger","year":"2011","unstructured":"Pfrieger FW, Ungerer N. Cholesterol metabolism in neurons and astrocytes. Prog Lipid Res. 2011;50(4):357\u201371. https:\/\/doi.org\/10.1016\/j.plipres.2011.06.002.","journal-title":"Prog Lipid Res"},{"issue":"4819","key":"951_CR3","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1126\/science.3306919","volume":"237","author":"C Le Goascogne","year":"1987","unstructured":"Le Goascogne C, Robel P, Gou\u00e9zou M, Sanan\u00e8s N, Baulieu EE, Waterman M. Neurosteroids: cytochrome P-450scc in rat brain. Science. 1987;237(4819):1212\u201315. https:\/\/doi.org\/10.1126\/science.3306919.","journal-title":"Science"},{"key":"951_CR4","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.plipres.2016.09.003","volume":"64","author":"AV Prabhu","year":"2016","unstructured":"Prabhu AV, Luu W, Li D, Sharpe LJ, Brown AJ. DHCR7: a vital enzyme switch between cholesterol and vitamin D production. Prog Lipid Res. 2016;64:138\u201351. https:\/\/doi.org\/10.1016\/j.plipres.2016.09.003.","journal-title":"Prog Lipid Res"},{"issue":"7937","key":"951_CR5","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41586-022-05439-w","volume":"611","author":"JW Blanchard","year":"2022","unstructured":"Blanchard JW, Akay LA, Davila-Velderrain J, von Maydell D, Mathys H, Davidson SM, et al. APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes. Nature. 2022;611(7937):769\u201379. https:\/\/doi.org\/10.1038\/s41586-022-05439-w.","journal-title":"Nature"},{"issue":"1","key":"951_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41593-020-00757-6","volume":"24","author":"SA Berghoff","year":"2021","unstructured":"Berghoff SA, Spieth L, Sun T, Hosang L, Schlaphoff L, Depp C, et al. Microglia facilitate repair of demyelinated lesions via post-squalene sterol synthesis. Nat Neurosci. 2021;24(1):47\u201360. https:\/\/doi.org\/10.1038\/s41593-020-00757-6.","journal-title":"Nat. Neurosci"},{"issue":"1","key":"951_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13024-022-00542-y","volume":"17","author":"RY Li","year":"2022","unstructured":"Li RY, Qin Q, Yang HC, Wang YY, Mi YX, Yin YS, et al. TREM2 in the pathogenesis of AD: a lipid metabolism regulator and potential metabolic therapeutic target. Mol Neurodegener. 2022;17(1):40. https:\/\/doi.org\/10.1186\/s13024-022-00542-y.","journal-title":"Mol Neurodegener"},{"issue":"4","key":"951_CR8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1515\/BC.2009.035","volume":"390","author":"JM Dietschy","year":"2009","unstructured":"Dietschy JM. Central nervous system: cholesterol turnover, brain development and neurodegeneration. Biol Chem. 2009;390(4):287\u201393. https:\/\/doi.org\/10.1515\/BC.2009.035.","journal-title":"Biol Chem"},{"issue":"5","key":"951_CR9","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.tins.2022.01.002","volume":"45","author":"D Li","year":"2022","unstructured":"Li D, Zhang J, Liu Q. Brain cell type-specific cholesterol metabolism and implications for learning and memory. Trends Neurosciences. 2022;45(5):401\u201314. https:\/\/doi.org\/10.1016\/j.tins.2022.01.002.","journal-title":"Trends Neurosciences"},{"issue":"4","key":"951_CR10","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.tins.2022.01.001","volume":"45","author":"SA Berghoff","year":"2022","unstructured":"Berghoff SA, Spieth L, Saher G. Local cholesterol metabolism orchestrates remyelination. Trends Neurosciences. 2022;45(4):272\u201383. https:\/\/doi.org\/10.1016\/j.tins.2022.01.001.","journal-title":"Trends Neurosciences"},{"issue":"5","key":"951_CR11","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41573-022-00390-x","volume":"21","author":"HG Lee","year":"2022","unstructured":"Lee HG, Wheeler MA, Quintana FJ. Function and therapeutic value of astrocytes in neurological diseases. Nat Rev Drug Discov. 2022;21(5):339\u201358. https:\/\/doi.org\/10.1038\/s41573-022-00390-x.","journal-title":"Nat Rev Drug Discov"},{"key":"951_CR12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3389\/fphys.2020.00393","volume":"11","author":"BA Loving","year":"2020","unstructured":"Loving BA, Bruce KD. Lipid and lipoprotein metabolism in microglia. Front Physiol. 2020;11:393. https:\/\/doi.org\/10.3389\/fphys.2020.00393.","journal-title":"Front. Physiol"},{"issue":"11","key":"951_CR13","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.stem.2024.09.014","volume":"31","author":"RB Ionescu","year":"2024","unstructured":"Ionescu RB, Nicaise AM, Reisz JA, Williams EC, Prasad P, Willis CM, et al. Increased cholesterol synthesis drives neurotoxicity in patient stem cell-derived model of multiple sclerosis. Cell Stem Cell. 2024;31(11):1574\u201390.e11. https:\/\/doi.org\/10.1016\/j.stem.2024.09.014.","journal-title":"Cell Stem Cell"},{"issue":"2","key":"951_CR14","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.cmet.2015.05.022","volume":"22","author":"A Roy","year":"2015","unstructured":"Roy A, Jana M, Kundu M, Corbett GT, Rangaswamy SB, Mishra RK, et al. HMG-CoA reductase inhibitors bind to PPAR\u03b1 to upregulate neurotrophin expression in the brain and improve memory in mice. Cell Metab. 2015;22(2):253\u201365. https:\/\/doi.org\/10.1016\/j.cmet.2015.05.022.","journal-title":"Cell Metab"},{"issue":"20","key":"951_CR15","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1016\/j.neuron.2023.07.005","volume":"111","author":"S Essayan-Perez","year":"2023","unstructured":"Essayan-Perez S, S\u00fcdhof TC. Neuronal \u03b3-secretase regulates lipid metabolism, linking cholesterol to synaptic dysfunction in Alzheimer\u2019s disease. Neuron. 2023;111(20):3176\u201394.e7. https:\/\/doi.org\/10.1016\/j.neuron.2023.07.005.","journal-title":"Neuron"},{"issue":"16","key":"951_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/ijms25168964","volume":"25","author":"A Pierzchli\u0144ska","year":"2024","unstructured":"Pierzchli\u0144ska A, S\u0142awek J, Kwa\u015bniak-Butowska M, Malinowski D, Komaniecka N, Mak M, et al. Genetic polymorphisms in the HMGCR gene and associations with cognitive decline in Parkinson\u2019s disease patients. Int J Mol Sci. 2024;25(16):25. https:\/\/doi.org\/10.3390\/ijms25168964.","journal-title":"IJMS"},{"issue":"17","key":"951_CR17","doi-asserted-by":"publisher","first-page":"4311","DOI":"10.1523\/JNEUROSCI.4720-07.2008","volume":"28","author":"S Schuster","year":"2008","unstructured":"Schuster S, Nadjar A, Guo JT, Li Q, Ittrich C, Hengerer B, et al. The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor lovastatin reduces severity of l-DOPA-induced abnormal involuntary movements in experimental Parkinson\u2019s disease. J Neurosci. 2008;28(17):4311\u201316. https:\/\/doi.org\/10.1523\/JNEUROSCI.4720-07.2008.","journal-title":"J Neurosci"},{"issue":"7","key":"951_CR18","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/mp.2014.81","volume":"20","author":"V Leduc","year":"2015","unstructured":"Leduc V, De Beaumont L, Th\u00e9roux L, Dea D, Aisen P, Petersen RC, et al. HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer\u2019s disease in a three cohorts study. Mol Psychiatry. 2015;20(7):867\u201373. https:\/\/doi.org\/10.1038\/mp.2014.81.","journal-title":"Mol. Psychiatry"},{"key":"951_CR19","doi-asserted-by":"publisher","unstructured":"Benn M, Nordestgaard BG, Frikke-Schmidt R, Tybj\u00e6rg-Hansen A. Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer\u2019s disease and Parkinson\u2019s disease: Mendelian randomisation study. BMJ. 2017;357:j1648. https:\/\/doi.org\/10.1136\/bmj.j1648.","DOI":"10.1136\/bmj.j1648"},{"issue":"2","key":"951_CR20","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.neuropharm.2007.05.003","volume":"53","author":"C Bate","year":"2007","unstructured":"Bate C, Williams A. Squalestatin protects neurons and reduces the activation of cytoplasmic phospholipase A2 by A\u03b21\u201342. Neuropharmacology. 2007;53(2):222\u201331. https:\/\/doi.org\/10.1016\/j.neuropharm.2007.05.003.","journal-title":"Neuropharmacology"},{"issue":"3","key":"951_CR21","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/cdd.2011.105","volume":"19","author":"L Lim","year":"2012","unstructured":"Lim L, Jackson-Lewis V, Wong LC, Shui GH, Goh AX, Kesavapany S, et al. Lanosterol induces mitochondrial uncoupling and protects dopaminergic neurons from cell death in a model for Parkinson\u2019s disease. Cell Death Differ. 2012;19(3):416\u201327. https:\/\/doi.org\/10.1038\/cdd.2011.105.","journal-title":"Cell Death Differ"},{"issue":"5","key":"951_CR22","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s12276-020-0430-0","volume":"52","author":"SH Lee","year":"2020","unstructured":"Lee SH, Lee JH, Im SS. The cellular function of SCAP in metabolic signaling. Exp Mol Med. 2020;52(5):724\u201329. https:\/\/doi.org\/10.1038\/s12276-020-0430-0.","journal-title":"Exp Mol Med"},{"issue":"1","key":"951_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cell.2005.12.022","volume":"124","author":"JL Goldstein","year":"2006","unstructured":"Goldstein JL, DeBose-Boyd RA, Brown MS. Protein sensors for membrane sterols. Cell. 2006;124(1):35\u201346. https:\/\/doi.org\/10.1016\/j.cell.2005.12.022.","journal-title":"Cell"},{"issue":"12","key":"951_CR24","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/nm.2064","volume":"15","author":"C Taghibiglou","year":"2009","unstructured":"Taghibiglou C, Martin HGS, Lai TW, Cho T, Prasad S, Kojic L, et al. Role of NMDA receptor\u2013dependent activation of SREBP1 in excitotoxic and ischemic neuronal injuries. Nat Med. 2009;15(12):1399\u2013406. https:\/\/doi.org\/10.1038\/nm.2064.","journal-title":"Nat Med"},{"issue":"6","key":"951_CR25","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.cmet.2010.11.006","volume":"12","author":"R Suzuki","year":"2010","unstructured":"Suzuki R, Lee K, Jing E, Biddinger SB, McDonald JG, Montine TJ, et al. Diabetes and insulin in regulation of brain cholesterol metabolism. Cell Metab. 2010;12(6):567\u201379. https:\/\/doi.org\/10.1016\/j.cmet.2010.11.006.","journal-title":"Cell Metab"},{"issue":"1\u20132","key":"951_CR26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cell.2014.12.019","volume":"160","author":"L Liu","year":"2015","unstructured":"Liu L, Zhang K, Sandoval H, Yamamoto S, Jaiswal M, Sanz E, et al. Glial lipid droplets and ROS induced by mitochondrial defects promote neurodegeneration. Cell. 2015;160(1\u20132):177\u201390. https:\/\/doi.org\/10.1016\/j.cell.2014.12.019.","journal-title":"Cell"},{"issue":"4","key":"951_CR27","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/glia.23120","volume":"65","author":"van Deijk Af","year":"2017","unstructured":"van Deijk Af, Camargo N, Timmerman J, Heistek T, Brouwers JF, Mogavero F, et al. Astrocyte lipid metabolism is critical for synapse development and function in vivo. Glia. 2017;65(4):670\u201382. https:\/\/doi.org\/10.1002\/glia.23120.","journal-title":"Glia"},{"key":"951_CR28","doi-asserted-by":"publisher","unstructured":"Camargo N, Goudriaan A, van Deijk A-LF, Otte WM, Brouwers JF, Lodder H, et al. Oligodendroglial myelination requires astrocyte-derived lipids. PLoS Biol. 2017;15(5):e1002605. https:\/\/doi.org\/10.1371\/journal.pbio.1002605.","DOI":"10.1371\/journal.pbio.1002605"},{"key":"951_CR29","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.bbi.2024.03.051","volume":"119","author":"W Zhu","year":"2024","unstructured":"Zhu W, Zhang H, Niu T, Liu K, Fareeduddin Mohammed Farooqui H, Sun R, et al. Microglial SCAP deficiency protects against diabetes-associated cognitive impairment through inhibiting NLRP3 inflammasome-mediated neuroinflammation. Brain Behav Immun. 2024;119:154\u201370. https:\/\/doi.org\/10.1016\/j.bbi.2024.03.051.","journal-title":"Brain Behav Immun"},{"issue":"3","key":"951_CR30","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1093\/hmg\/ddz298","volume":"29","author":"A Di Pardo","year":"2020","unstructured":"Di Pardo A, Monyror J, Morales LC, Kadam V, Lingrell S, Maglione V, et al. Mutant huntingtin interacts with the sterol regulatory element-binding proteins and impairs their nuclear import. Hum Mol Genet. 2020;29(3):418\u201331. https:\/\/doi.org\/10.1093\/hmg\/ddz298.","journal-title":"Hum Mol Genet"},{"issue":"43","key":"951_CR31","doi-asserted-by":"publisher","first-page":"9932","DOI":"10.1523\/JNEUROSCI.3355-05.2005","volume":"25","author":"M Valenza","year":"2005","unstructured":"Valenza M, Rigamonti D, Goffredo D, Zuccato C, Fenu S, Jamot L, et al. Dysfunction of the cholesterol biosynthetic pathway in Huntington\u2019s disease. J Neurosci. 2005;25(43):9932\u201339. https:\/\/doi.org\/10.1523\/JNEUROSCI.3355-05.2005.","journal-title":"J Neurosci"},{"issue":"10","key":"951_CR32","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1093\/brain\/awab186","volume":"144","author":"G Birolini","year":"2021","unstructured":"Birolini G, Verlengia G, Talpo F, Maniezzi C, Zentilin L, Giacca M, et al. SREBP2 gene therapy targeting striatal astrocytes ameliorates Huntington\u2019s disease phenotypes. Brain. 2021;144(10):3175\u201390. https:\/\/doi.org\/10.1093\/brain\/awab186.","journal-title":"Brain"},{"issue":"1","key":"951_CR33","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.neulet.2008.10.023","volume":"448","author":"S Patassini","year":"2008","unstructured":"Patassini S, Giamp\u00e0 C, Martorana A, Bernardi G, Fusco FR. Effects of simvastatin on neuroprotection and modulation of Bcl-2 and BAX in the rat quinolinic acid model of Huntington\u2019s disease. Neurosci Lett. 2008;448(1):166\u201369. https:\/\/doi.org\/10.1016\/j.neulet.2008.10.023.","journal-title":"Neurosci Lett"},{"issue":"1\u20133","key":"951_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2013.03.042","volume":"709","author":"A Kumar","year":"2013","unstructured":"Kumar A, Sharma N, Mishra J, Kalonia H. Synergistical neuroprotection of rofecoxib and statins against malonic acid induced Huntington\u2019s disease like symptoms and related cognitive dysfunction in rats. Eur J Pharmacol. 2013;709(1\u20133):1\u201312. https:\/\/doi.org\/10.1016\/j.ejphar.2013.03.042.","journal-title":"Eur J Pharmacol"},{"issue":"10","key":"951_CR35","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1084\/jem.20210227","volume":"218","author":"G Gouna","year":"2021","unstructured":"Gouna G, Klose C, Bosch-Queralt M, Liu L, Gokce O, Schifferer M, et al. TREM2-dependent lipid droplet biogenesis in phagocytes is required for remyelination. J Exp Med. 2021;218(10):218. https:\/\/doi.org\/10.1084\/jem.20210227.","journal-title":"J Exp Med"},{"issue":"10","key":"951_CR36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/biom14101301","volume":"14","author":"TN Huynh","year":"2024","unstructured":"Huynh TN, Havrda MC, Zanazzi GJ, Chang CCY, Chang TY. Inhibiting the cholesterol storage enzyme ACAT1\/SOAT1 in myelin debris-treated microglial cell lines activates the gene expression of cholesterol efflux transporter ABCA1. Biomolecules. 2024;14(10):14. https:\/\/doi.org\/10.3390\/biom14101301.","journal-title":"Biomolecules"},{"issue":"43","key":"951_CR37","doi-asserted-by":"publisher","first-page":"15836","DOI":"10.1074\/jbc.RA119.010564","volume":"294","author":"EM Melton","year":"2019","unstructured":"Melton EM, Li H, Benson J, Sohn P, Huang LH, Song BL, et al. Myeloid Acat1\/Soat1 KO attenuates pro-inflammatory responses in macrophages and protects against atherosclerosis in a model of advanced lesions. J Biol Chem. 2019;294(43):15836\u201349. https:\/\/doi.org\/10.1074\/jbc.RA119.010564.","journal-title":"J Biol Chem"},{"issue":"5","key":"951_CR38","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1194\/jlr.M800584-JLR200","volume":"50","author":"V Hirsch-Reinshagen","year":"2009","unstructured":"Hirsch-Reinshagen V, Donkin J, Stukas S, Chan J, Wilkinson A, Fan J, et al. LCAT synthesized by primary astrocytes esterifies cholesterol on glia-derived lipoproteins. J Lipid Res. 2009;50(5):885\u201393. https:\/\/doi.org\/10.1194\/jlr.M800584-JLR200.","journal-title":"J Lipid Res"},{"issue":"8","key":"951_CR39","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1194\/jlr.M049940","volume":"55","author":"S Stukas","year":"2014","unstructured":"Stukas S, Freeman L, Lee M, Wilkinson A, Ossoli A, Vaisman B, et al. LCAT deficiency does not impair amyloid metabolism in APP\/PS1 mice. J Lipid Res. 2014;55(8):1721\u201329. https:\/\/doi.org\/10.1194\/jlr.M049940.","journal-title":"J Lipid Res"},{"issue":"11","key":"951_CR40","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1161\/CIRCRESAHA.110.226613","volume":"107","author":"M Igarashi","year":"2010","unstructured":"Igarashi M, Osuga J, Uozaki H, Sekiya M, Nagashima S, Takahashi M, et al. The critical role of neutral cholesterol ester hydrolase 1 in cholesterol removal from human macrophages. Circ Res. 2010;107(11):1387\u201395. https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.226613.","journal-title":"Circ Res"},{"issue":"19","key":"951_CR41","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1093\/hmg\/ddx269","volume":"26","author":"S Zhang","year":"2017","unstructured":"Zhang S, Glukhova SA, Caldwell KA, Caldwell GA. NCEH-1 modulates cholesterol metabolism and protects against \u03b1-synuclein toxicity in a C. elegans model of Parkinson\u2019s disease. Hum Mol Genet. 2017;26(19):3823\u201336. https:\/\/doi.org\/10.1093\/hmg\/ddx269.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"951_CR42","doi-asserted-by":"publisher","first-page":"20314","DOI":"10.1038\/s41598-020-76973-8","volume":"10","author":"GR Phillips","year":"2020","unstructured":"Phillips GR, Hancock SE, Brown SHJ, Jenner AM, Kreilaus F, Newell KA, et al. Cholesteryl ester levels are elevated in the caudate and putamen of Huntington\u2019s disease patients. Sci Rep. 2020;10(1):20314. https:\/\/doi.org\/10.1038\/s41598-020-76973-8.","journal-title":"Sci Rep"},{"issue":"1","key":"951_CR43","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1146\/annurev-physiol-031620-094944","volume":"83","author":"AM Plummer","year":"2021","unstructured":"Plummer AM, Culbertson AT, Liao M. The ABCs of sterol transport. Annu Rev Physiol. 2021;83(1):153\u201381. https:\/\/doi.org\/10.1146\/annurev-physiol-031620-094944.","journal-title":"Annu Rev Physiol"},{"key":"951_CR44","doi-asserted-by":"publisher","first-page":"4591","DOI":"10.12659\/MSM.903636","volume":"23","author":"L Ya","year":"2017","unstructured":"Ya L, Lu Z. Differences in ABCA1 R219K polymorphisms and serum indexes in Alzheimer and Parkinson diseases in northern China. Med Sci Monit. 2017;23:4591\u2013600. https:\/\/doi.org\/10.12659\/MSM.903636.","journal-title":"Med Sci Monit"},{"issue":"8","key":"951_CR45","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1194\/jlr.P091033","volume":"60","author":"C Marchi","year":"2019","unstructured":"Marchi C, Adorni MP, Caffarra P, Ronda N, Spallazzi M, Barocco F, et al. ABCA1- and ABCG1-mediated cholesterol efflux capacity of cerebrospinal fluid is impaired in Alzheimer\u2019s disease. J Lipid Res. 2019;60(8):1449\u201356. https:\/\/doi.org\/10.1194\/jlr.P091033.","journal-title":"J Lipid Res"},{"issue":"12","key":"951_CR46","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/j.jalz.2015.04.006","volume":"11","author":"LT Nordestgaard","year":"2015","unstructured":"Nordestgaard LT, Tybj\u00e6rg-Hansen A, Nordestgaard BG, Frikke-Schmidt R. Loss-of-function mutation in ABCA1 and risk of Alzheimer\u2019s disease and cerebrovascular disease. Alzheimers Dementia. 2015;11(12):1430\u201338. https:\/\/doi.org\/10.1016\/j.jalz.2015.04.006.","journal-title":"Alzheimers Dementia"},{"issue":"5","key":"951_CR47","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s11011-025-01642-6","volume":"40","author":"A Sharma","year":"2025","unstructured":"Sharma A, Mannan A, Singh TG. Unraveling novel mechanisms of ATP-binding cassette (ABC) transporter in insulin resistance-induced amyloidogenesis. Metab Brain Dis. 2025;40(5):218. https:\/\/doi.org\/10.1007\/s11011-025-01642-6.","journal-title":"Metab Brain Dis"},{"key":"951_CR48","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1172\/JCI33622","volume":"118","author":"SE Wahrle","year":"2008","unstructured":"Wahrle SE, Jiang H, Parsadanian M, Kim J, Li A, Knoten A, et al. Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease. J Clin Invest. 2008;118:671\u201382. https:\/\/doi.org\/10.1172\/JCI33622.","journal-title":"J. Clin. Invest"},{"issue":"52","key":"951_CR49","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1073\/pnas.2112095118","volume":"118","author":"MJ Moulton","year":"2021","unstructured":"Moulton MJ, Barish S, Ralhan I, Chang J, Goodman LD, Harland JG, et al. Neuronal ROS-induced glial lipid droplet formation is altered by loss of Alzheimer\u2019s disease\u2013associated genes. Proc Natl Acad Sci USA. 2021;118(52):118. https:\/\/doi.org\/10.1073\/pnas.2112095118.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"39","key":"951_CR50","doi-asserted-by":"publisher","first-page":"40987","DOI":"10.1074\/jbc.M407963200","volume":"279","author":"SE Wahrle","year":"2004","unstructured":"Wahrle SE, Jiang H, Parsadanian M, Legleiter J, Han X, Fryer JD, et al. ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE. J Biol Chem. 2004;279(39):40987\u201393. https:\/\/doi.org\/10.1074\/jbc.M407963200.","journal-title":"J Biol Chem"},{"issue":"7","key":"951_CR51","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1080\/14728222.2023.2235718","volume":"27","author":"T Paseban","year":"2023","unstructured":"Paseban T, Alavi MS, Etemad L, Roohbakhsh A. The role of the ATP-Binding cassette A1 (ABCA1) in neurological disorders: a mechanistic review. Expert Opin Ther Targets. 2023;27(7):531\u201352. https:\/\/doi.org\/10.1080\/14728222.2023.2235718.","journal-title":"Expert Opin Ther Targets"},{"key":"951_CR52","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.nbd.2013.01.018","volume":"54","author":"JM Karasinska","year":"2013","unstructured":"Karasinska JM, de Haan W, Franciosi S, Ruddle P, Fan J, Kruit JK, et al. ABCA1 influences neuroinflammation and neuronal death. Neurobiol Dis. 2013;54:445\u201355. https:\/\/doi.org\/10.1016\/j.nbd.2013.01.018.","journal-title":"Neurobiol Disease"},{"issue":"4","key":"951_CR53","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/cdd.2014.162","volume":"22","author":"M Valenza","year":"2015","unstructured":"Valenza M, Marullo M, Di Paolo E, Cesana E, Zuccato C, Biella G, et al. Disruption of astrocyte-neuron cholesterol cross talk affects neuronal function in Huntington\u2019s disease. Cell Death Differ. 2015;22(4):690\u2013702. https:\/\/doi.org\/10.1038\/cdd.2014.162.","journal-title":"Cell Death Differ"},{"issue":"7","key":"951_CR54","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1136\/jmg.2009.066399","volume":"46","author":"M Futter","year":"2009","unstructured":"Futter M, Diekmann H, Schoenmakers E, Sadiq O, Chatterjee K, Rubinsztein DC. Wild-type but not mutant huntingtin modulates the transcriptional activity of liver X receptors. J Med Genet. 2009;46(7):438\u201346. https:\/\/doi.org\/10.1136\/jmg.2009.066399.","journal-title":"J Med Genet"},{"issue":"1","key":"951_CR55","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13024-023-00671-y","volume":"18","author":"T Poliakova","year":"2023","unstructured":"Poliakova T, Wellington CL. Roles of peripheral lipoproteins and cholesteryl ester transfer protein in the vascular contributions to cognitive impairment and dementia. Mol Neurodegener. 2023;18(1):86. https:\/\/doi.org\/10.1186\/s13024-023-00671-y.","journal-title":"Mol Neurodegener"},{"key":"951_CR56","doi-asserted-by":"publisher","first-page":"108486","DOI":"10.1016\/j.pharmthera.2023.108486","volume":"249","author":"SB Hansen","year":"2023","unstructured":"Hansen SB, Wang H. The shared role of cholesterol in neuronal and peripheral inflammation. Pharmacol Ther. 2023;249:108486. https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108486.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"951_CR57","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41583-023-00776-9","volume":"25","author":"J Blumenfeld","year":"2024","unstructured":"Blumenfeld J, Yip O, Kim MJ, Huang Y. Cell type-specific roles of APOE4 in Alzheimer disease. Nat Rev Neurosci. 2024;25(2):91\u2013110. https:\/\/doi.org\/10.1038\/s41583-023-00776-9.","journal-title":"Nat. Rev. Neurosci"},{"issue":"12","key":"951_CR58","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1038\/s44321-024-00162-7","volume":"16","author":"P Preman","year":"2024","unstructured":"Preman P, Moechars D, Fertan E, Wolfs L, Serneels L, Shah D, et al. APOE from astrocytes restores Alzheimer\u2019s a\u03b2-pathology and DAM-like responses in APOE deficient microglia. EMBO Mol Med. 2024;16(12):3113\u201341. https:\/\/doi.org\/10.1038\/s44321-024-00162-7.","journal-title":"EMBO Mol Med"},{"issue":"1","key":"951_CR59","doi-asserted-by":"publisher","first-page":"108572","DOI":"10.1016\/j.celrep.2020.108572","volume":"34","author":"G Qi","year":"2021","unstructured":"Qi G, Mi Y, Shi X, Gu H, Brinton RD, Yin F. ApoE4 impairs Neuron-astrocyte coupling of fatty acid metabolism. Cell Rep. 2021;34(1):108572. https:\/\/doi.org\/10.1016\/j.celrep.2020.108572.","journal-title":"Cell Rep"},{"key":"951_CR60","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fnagi.2019.00014","volume":"11","author":"CG Fernandez","year":"2019","unstructured":"Fernandez CG, Hamby ME, McReynolds ML, Ray WJ. The role of APOE4 in disrupting the homeostatic functions of astrocytes and microglia in aging and Alzheimer\u2019s disease. Front Aging Neurosci. 2019;11:14. https:\/\/doi.org\/10.3389\/fnagi.2019.00014.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"951_CR61","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41531-024-00753-8","volume":"10","author":"Y Dai","year":"2024","unstructured":"Dai Y, Bi M, Jiao Q, Du X, Yan C, Jiang H. Astrocyte-derived apolipoprotein D is required for neuronal survival in Parkinson\u2019s disease. Npj Parkinsons Dis. 2024;10(1):143. https:\/\/doi.org\/10.1038\/s41531-024-00753-8.","journal-title":"Npj Parkinsons Dis"},{"issue":"8","key":"951_CR62","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1021\/acschemneuro.9b00248","volume":"10","author":"TC Genaro-Mattos","year":"2019","unstructured":"Genaro-Mattos TC, Anderson A, Allen LB, Korade Z, Mirnics K. Cholesterol biosynthesis and uptake in developing neurons. ACS Chem Neurosci. 2019;10(8):3671\u201381. https:\/\/doi.org\/10.1021\/acschemneuro.9b00248.","journal-title":"ACS Chem. Neurosci"},{"issue":"2","key":"951_CR63","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/cvr\/cvad159","volume":"120","author":"M Borrell-Pages","year":"2024","unstructured":"Borrell-Pages M, Luquero A, Vilahur G, Padr\u00f3 T, Badimon L. Canonical wnt pathway and the LDL receptor superfamily in neuronal cholesterol homeostasis and function. Cardiovasc Res. 2024;120(2):140\u201351. https:\/\/doi.org\/10.1093\/cvr\/cvad159.","journal-title":"Cardiovasc Res"},{"issue":"20","key":"951_CR64","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/ijms232012192","volume":"23","author":"B Papotti","year":"2022","unstructured":"Papotti B, Adorni MP, Marchi C, Zimetti F, Ronda N, Panighel G, et al. PCSK9 affects astrocyte cholesterol metabolism and reduces neuron cholesterol supplying in vitro: potential implications in Alzheimer\u2019s disease. Int J Mol Sci. 2022;23(20):23. https:\/\/doi.org\/10.3390\/ijms232012192.","journal-title":"IJMS"},{"key":"951_CR65","doi-asserted-by":"publisher","first-page":"107652","DOI":"10.1016\/j.phrs.2025.107652","volume":"213","author":"S Pelucchi","year":"2025","unstructured":"Pelucchi S, Da Dalt L, De Cesare G, Stringhi R, D\u2019Andrea L, La Greca F, et al. Neuronal PCSK9 regulates cognitive performances via the modulation of ApoER2 synaptic localization. Pharmacol Res. 2025;213:107652. https:\/\/doi.org\/10.1016\/j.phrs.2025.107652.","journal-title":"Pharmacological Res"},{"issue":"1","key":"951_CR66","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13024-022-00560-w","volume":"17","author":"K Chen","year":"2022","unstructured":"Chen K, Martens YA, Meneses A, Ryu DH, Lu W, Raulin AC, et al. LRP1 is a neuronal receptor for \u03b1-synuclein uptake and spread. Mol Neurodegener. 2022;17(1):57. https:\/\/doi.org\/10.1186\/s13024-022-00560-w.","journal-title":"Mol Neurodegener"},{"issue":"7803","key":"951_CR67","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41586-020-2156-5","volume":"580","author":"JN Rauch","year":"2020","unstructured":"Rauch JN, Luna G, Guzman E, Audouard M, Challis C, Sibih YE, et al. LRP1 is a master regulator of tau uptake and spread. Nature. 2020;580(7803):381\u201385. https:\/\/doi.org\/10.1038\/s41586-020-2156-5.","journal-title":"Nature"},{"issue":"14","key":"951_CR68","doi-asserted-by":"publisher","first-page":"5851","DOI":"10.1523\/JNEUROSCI.5180-14.2015","volume":"35","author":"CC Liu","year":"2015","unstructured":"Liu CC, Hu J, Tsai CW, Yue M, Melrose HL, Kanekiyo T, et al. Neuronal LRP1 regulates glucose metabolism and insulin signaling in the brain. J Neurosci. 2015;35(14):5851\u201359. https:\/\/doi.org\/10.1523\/JNEUROSCI.5180-14.2015.","journal-title":"J Neurosci"},{"issue":"3","key":"951_CR69","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3233\/JAD-2010-091504","volume":"20","author":"L Mosconi","year":"2010","unstructured":"Mosconi L, Berti V, Glodzik L, Pupi A, De Santi S, de Leon MJ. Pre-clinical detection of Alzheimer\u2019s disease using FDG-PET, with or without amyloid imaging. J Alzheimers Dis. 2010;20(3):843\u201354. https:\/\/doi.org\/10.3233\/JAD-2010-091504.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"951_CR70","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.neuron.2021.01.005","volume":"109","author":"X Li","year":"2021","unstructured":"Li X, Zhang J, Li D, He C, He K, Xue T, et al. Astrocytic ApoE reprograms neuronal cholesterol metabolism and histone-acetylation-mediated memory. Neuron. 2021;109(6):957\u201370.e8. https:\/\/doi.org\/10.1016\/j.neuron.2021.01.005.","journal-title":"Neuron"},{"issue":"13","key":"951_CR71","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.cell.2022.05.017","volume":"185","author":"J Tcw","year":"2022","unstructured":"Tcw J, Qian L, Pipalia NH, Chao MJ, Liang SA, Shi Y, et al. Cholesterol and matrisome pathways dysregulated in astrocytes and microglia. Cell. 2022;185(13):2213\u201333.e25. https:\/\/doi.org\/10.1016\/j.cell.2022.05.017.","journal-title":"Cell"},{"issue":"4","key":"951_CR72","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/glia.20772","volume":"57","author":"A Pocivavsek","year":"2009","unstructured":"Pocivavsek A, Burns MP, Rebeck GW. Low-density lipoprotein receptors regulate microglial inflammation through c-Jun N-terminal kinase. Glia. 2009;57(4):444\u201353. https:\/\/doi.org\/10.1002\/glia.20772.","journal-title":"Glia"},{"issue":"45","key":"951_CR73","doi-asserted-by":"publisher","first-page":"18699","DOI":"10.1074\/jbc.M117.798413","volume":"292","author":"C Brifault","year":"2017","unstructured":"Brifault C, Gilder AS, Laudati E, Banki M, Gonias SL. Shedding of membrane-associated LDL receptor-related protein-1 from microglia amplifies and sustains neuroinflammation. J Biol Chem. 2017;292(45):18699\u2013712. https:\/\/doi.org\/10.1074\/jbc.M117.798413.","journal-title":"J Biol Chem"},{"issue":"15","key":"951_CR74","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1016\/j.neuron.2021.05.034","volume":"109","author":"Y Shi","year":"2021","unstructured":"Shi Y, Andhey PS, Ising C, Wang K, Snipes LL, Boyer K, et al. Overexpressing low-density lipoprotein receptor reduces tau-associated neurodegeneration in relation to apoE-linked mechanisms. Neuron. 2021;109(15):2413\u201326.e7. https:\/\/doi.org\/10.1016\/j.neuron.2021.05.034.","journal-title":"Neuron"},{"key":"951_CR75","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.bbi.2024.04.014","volume":"119","author":"LQ Zhou","year":"2024","unstructured":"Zhou LQ, Chu YH, Dong MH, Yang S, Chen M, Tang Y, et al. Ldl-stimulated microglial activation exacerbates ischemic white matter damage. Brain Behav Immun. 2024;119:416\u201330. https:\/\/doi.org\/10.1016\/j.bbi.2024.04.014.","journal-title":"Brain Behav Immun"},{"issue":"5","key":"951_CR76","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.neuron.2019.12.007","volume":"105","author":"AA Nugent","year":"2020","unstructured":"Nugent AA, Lin K, van Lengerich B, Lianoglou S, Przybyla L, Davis SS, et al. TREM2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge. Neuron. 2020;105(5):837\u201354.e9. https:\/\/doi.org\/10.1016\/j.neuron.2019.12.007.","journal-title":"Neuron"},{"issue":"5","key":"951_CR77","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.tins.2025.02.010","volume":"48","author":"J Li","year":"2025","unstructured":"Li J, Fiore F, Monk KR, Agarwal A. Spatiotemporal calcium dynamics orchestrate oligodendrocyte development and myelination. Trends Neurosciences. 2025;48(5):377\u201388. https:\/\/doi.org\/10.1016\/j.tins.2025.02.010.","journal-title":"Trends Neurosciences"},{"issue":"1","key":"951_CR78","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1172\/JCI128114","volume":"131","author":"Y Xie","year":"2021","unstructured":"Xie Y, Zhang X, Xu P, Zhao N, Zhao Y, Li Y, et al. Aberrant oligodendroglial LDL receptor orchestrates demyelination in chronic cerebral ischemia. J Clin Invest. 2021;131(1):131. https:\/\/doi.org\/10.1172\/JCI128114.","journal-title":"J Clin Investigation"},{"key":"951_CR79","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.arr.2016.02.002","volume":"27","author":"M El Haj","year":"2016","unstructured":"El Haj M, Antoine P, Amouyel P, Lambert JC, Pasquier F, Kapogiannis D. Apolipoprotein E (APOE) \u03b54 and episodic memory decline in Alzheimer\u2019s disease: a review. Ageing Res Rev. 2016;27:15\u201322. https:\/\/doi.org\/10.1016\/j.arr.2016.02.002.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"951_CR80","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/jnc.15748","volume":"165","author":"KK-S Mok","year":"2023","unstructured":"Mok KK-S, Yeung SH-S, Cheng GW-Y, Ma IW-T, Lee RH-S, Herrup K, et al. Apolipoprotein E \u03b54 disrupts oligodendrocyte differentiation by interfering with astrocyte-derived lipid transport. J Neurochem. 2023;165(1):55\u201375. https:\/\/doi.org\/10.1111\/jnc.15748.","journal-title":"J Neurochem"},{"issue":"32","key":"951_CR81","doi-asserted-by":"publisher","first-page":"10844","DOI":"10.1523\/JNEUROSCI.0917-10.2010","volume":"30","author":"M Valenza","year":"2010","unstructured":"Valenza M, Leoni V, Karasinska JM, Petricca L, Fan J, Carroll J, et al. Cholesterol defect is marked across multiple rodent models of Huntington\u2019s disease and is manifest in astrocytes. J Neurosci. 2010;30(32):10844\u201350. https:\/\/doi.org\/10.1523\/JNEUROSCI.0917-10.2010.","journal-title":"J Neurosci"},{"key":"951_CR82","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.plipres.2016.09.002","volume":"64","author":"V Mutemberezi","year":"2016","unstructured":"Mutemberezi V, Guillemot-Legris O, Muccioli GG. Oxysterols: from cholesterol metabolites to key mediators. Prog Lipid Res. 2016;64:152\u201369. https:\/\/doi.org\/10.1016\/j.plipres.2016.09.002.","journal-title":"Prog Lipid Res"},{"issue":"1","key":"951_CR83","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1146\/annurev-pharmtox-010715-103233","volume":"56","author":"W Luu","year":"2016","unstructured":"Luu W, Sharpe LJ, Capell-Hattam I, Gelissen IC, Brown AJ. Oxysterols: old tale, new twists. Annu Rev Pharmacol Toxicol. 2016;56(1):447\u201367. https:\/\/doi.org\/10.1146\/annurev-pharmtox-010715-103233.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"951_CR84","doi-asserted-by":"publisher","first-page":"110","DOI":"10.2174\/0929867327666200316142659","volume":"28","author":"A Samadi","year":"2020","unstructured":"Samadi A, Sabuncuoglu S, Samadi M, Isikhan SY, Chirumbolo S, Peana M, et al. A comprehensive review on oxysterols and related diseases. Curr Med Chem. 2020;28(1):110\u201336. https:\/\/doi.org\/10.2174\/0929867327666200316142659.","journal-title":"CMC"},{"key":"951_CR85","doi-asserted-by":"publisher","first-page":"1268104","DOI":"10.3389\/fimmu.2023.1268104","volume":"14","author":"J Zhang","year":"2023","unstructured":"Zhang J, Zhu Y, Wang X, Wang J. 25-hydroxycholesterol: an integrator of antiviral ability and signaling. Front Immunol. 2023;14:1268104. https:\/\/doi.org\/10.3389\/fimmu.2023.1268104.","journal-title":"Front. Immunol"},{"issue":"1","key":"951_CR86","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/bies.10195","volume":"25","author":"FW Pfrieger","year":"2003","unstructured":"Pfrieger FW. Outsourcing in the brain: do neurons depend on cholesterol delivery by astrocytes? Bioessays. 2003;25(1):72\u201378. https:\/\/doi.org\/10.1002\/bies.10195.","journal-title":"Bioessays"},{"issue":"11","key":"951_CR87","doi-asserted-by":"publisher","first-page":"5749","DOI":"10.1073\/pnas.1917421117","volume":"117","author":"E Yutuc","year":"2020","unstructured":"Yutuc E, Angelini R, Baumert M, Mast N, Pikuleva I, Newton J, et al. Localization of sterols and oxysterols in mouse brain reveals distinct spatial cholesterol metabolism. Proc Natl Acad Sci USA. 2020;117(11):5749\u201360. https:\/\/doi.org\/10.1073\/pnas.1917421117.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"951_CR88","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/antiox10050740","volume":"10","author":"P Gamba","year":"2021","unstructured":"Gamba P, Giannelli S, Staurenghi E, Testa G, Sottero B, Biasi F, et al. The controversial role of 24-S-hydroxycholesterol in Alzheimer\u2019s disease. Antioxidants (Basel). 2021;10(5):10. https:\/\/doi.org\/10.3390\/antiox10050740.","journal-title":"Antioxid (Basel)"},{"issue":"21","key":"951_CR89","doi-asserted-by":"publisher","first-page":"5965","DOI":"10.1093\/hmg\/ddv268","volume":"24","author":"MA Burlot","year":"2015","unstructured":"Burlot MA, Braudeau J, Michaelsen-Preusse K, Potier B, Ayciriex S, Varin J, et al. Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like tau pathology. Hum Mol Genet. 2015;24(21):5965\u201376. https:\/\/doi.org\/10.1093\/hmg\/ddv268.","journal-title":"Hum Mol Genet"},{"issue":"10","key":"951_CR90","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1073\/pnas.0600316103","volume":"103","author":"TJ Kotti","year":"2006","unstructured":"Kotti TJ, Ramirez DMO, Pfeiffer BE, Huber KM, Russell DW. Brain cholesterol turnover required for geranylgeraniol production and learning in mice. Proc Natl Acad Sci USA. 2006;103(10):3869\u201374. https:\/\/doi.org\/10.1073\/pnas.0600316103.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"951_CR91","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/antiox12030631","volume":"12","author":"G Testa","year":"2023","unstructured":"Testa G, Giannelli S, Sottero B, Staurenghi E, Giaccone G, Caroppo P, et al. 24-hydroxycholesterol induces tau proteasome-dependent degradation via the SIRT1\/PGC1\u03b1\/Nrf2 pathway: a potential mechanism to counteract Alzheimer\u2019s disease. Antioxidants (Basel). 2023;12(3):12. https:\/\/doi.org\/10.3390\/antiox12030631.","journal-title":"Antioxid (Basel)"},{"key":"951_CR92","doi-asserted-by":"publisher","unstructured":"Latorre-Leal M, Rodriguez-Rodriguez P, Franchini L, Nikolidakis O, Daniilidou M, Delac L, et al. CYP46A1-mediated cholesterol turnover induces sex-specific changes in cognition and counteracts memory loss in ovariectomized mice. Sci Adv. 2024;10(4):eadj1354. https:\/\/doi.org\/10.1126\/sciadv.adj1354.","DOI":"10.1126\/sciadv.adj1354"},{"issue":"4","key":"951_CR93","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3233\/JAD-130035","volume":"36","author":"V Leoni","year":"2013","unstructured":"Leoni V, Solomon A, L\u00f6vgren-Sandblom A, Minthon L, Blennow K, Hansson O, et al. Diagnostic power of 24S-hydroxycholesterol in cerebrospinal fluid: candidate marker of brain health. J Alzheimer\u2019s Disease. 2013;36(4):739\u201347. https:\/\/doi.org\/10.3233\/JAD-130035.","journal-title":"J Alzheimer\u2019s Disease"},{"issue":"1\u20132","key":"951_CR94","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.neulet.2005.11.046","volume":"397","author":"V Leoni","year":"2006","unstructured":"Leoni V, Shafaati M, Salomon A, Kivipelto M, Bj\u00f6rkhem I, Wahlund LO. Are the CSF levels of 24S-hydroxycholesterol a sensitive biomarker for mild cognitive impairment? Neurosci Lett. 2006;397(1\u20132):83\u201387. https:\/\/doi.org\/10.1016\/j.neulet.2005.11.046.","journal-title":"Neurosci Lett"},{"issue":"1","key":"951_CR95","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s13195-022-01151-z","volume":"14","author":"AJ Lerner","year":"2022","unstructured":"Lerner AJ, Arnold SE, Maxfield E, Koenig A, Toth ME, Fortin B, et al. CYP46A1 activation by low-dose efavirenz enhances brain cholesterol metabolism in subjects with early Alzheimer\u2019s disease. Alz Res Ther. 2022;14(1):198. https:\/\/doi.org\/10.1186\/s13195-022-01151-z.","journal-title":"Alz Res Ther"},{"issue":"28","key":"951_CR96","doi-asserted-by":"publisher","first-page":"24666","DOI":"10.1074\/jbc.M111.236273","volume":"286","author":"K Yamanaka","year":"2011","unstructured":"Yamanaka K, Saito Y, Yamamori T, Urano Y, Noguchi N. 24(S)-hydroxycholesterol induces neuronal cell death through necroptosis, a form of programmed necrosis. J Biol Chem. 2011;286(28):24666\u201373. https:\/\/doi.org\/10.1074\/jbc.M111.236273.","journal-title":"J Biol Chem"},{"key":"951_CR97","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.mce.2019.02.013","volume":"486","author":"L Cigliano","year":"2019","unstructured":"Cigliano L, Spagnuolo MS, Napolitano G, Iannotta L, Fasciolo G, Barone D, et al. 24S-hydroxycholesterol affects redox homeostasis in human glial U-87 MG cells. Mol Cell Endocrinol. 2019;486:25\u201333. https:\/\/doi.org\/10.1016\/j.mce.2019.02.013.","journal-title":"Mol Cellular Endocrinol"},{"key":"951_CR98","doi-asserted-by":"publisher","first-page":"842814","DOI":"10.3389\/fnins.2022.842814","volume":"16","author":"M Wu","year":"2022","unstructured":"Wu M, Zhai Y, Liang X, Chen W, Lin R, Ma L, et al. Connecting the dots between hypercholesterolemia and Alzheimer\u2019s disease: a potential mechanism based on 27-hydroxycholesterol. Front Neurosci. 2022;16:842814. https:\/\/doi.org\/10.3389\/fnins.2022.842814.","journal-title":"Front. Neurosci"},{"issue":"1","key":"951_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1326-4-1","volume":"4","author":"JR Prasanthi","year":"2009","unstructured":"Prasanthi JR, Huls A, Thomasson S, Thompson A, Schommer E, Ghribi O. Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on \u03b2-amyloid precursor protein levels and processing in human neuroblastoma SH-SY5Y cells. Mol Neurodegener. 2009;4(1):1. https:\/\/doi.org\/10.1186\/1750-1326-4-1.","journal-title":"Mol Neurodegener"},{"issue":"8","key":"951_CR100","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/ijms23084370","volume":"23","author":"T Wang","year":"2022","unstructured":"Wang T, Cui S, Hao L, Liu W, Wang L, Ju M, et al. Regulation of Th17\/Treg balance by 27-hydroxycholesterol and 24S-hydroxycholesterol correlates with learning and memory ability in mice. Int J Mol Sci. 2022;23(8):23. https:\/\/doi.org\/10.3390\/ijms23084370.","journal-title":"IJMS"},{"issue":"5","key":"951_CR101","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1002\/fsn3.1005","volume":"7","author":"WW Ma","year":"2019","unstructured":"Ma WW, Li CQ, Zhao L, Wang YS, Xiao R. NF-\u03baB-mediated inflammatory damage is differentially affected in SH-SY5Y and C6 cells treated with 27-hydroxycholesterol. Food Sci Nutr. 2019;7(5):1685\u201394. https:\/\/doi.org\/10.1002\/fsn3.1005.","journal-title":"Food Sci Nutr"},{"issue":"10","key":"951_CR102","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/nm1641","volume":"13","author":"M Umetani","year":"2007","unstructured":"Umetani M, Domoto H, Gormley AK, Yuhanna IS, Cummins CL, Javitt NB, et al. 27-hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. Nat Med. 2007;13(10):1185\u201392. https:\/\/doi.org\/10.1038\/nm1641.","journal-title":"Nat Med"},{"issue":"29","key":"951_CR103","doi-asserted-by":"publisher","first-page":"25574","DOI":"10.1074\/jbc.M111.236877","volume":"286","author":"L Mateos","year":"2011","unstructured":"Mateos L, Ismail MAM, Gil-Bea FJ, Sch\u00fcle R, Sch\u00f6ls L, Heverin M, et al. Side chain-oxidized oxysterols regulate the brain renin-angiotensin system through a liver X receptor-dependent mechanism. J Biol Chem. 2011;286(29):25574\u201385. https:\/\/doi.org\/10.1074\/jbc.M111.236877.","journal-title":"J Biol Chem"},{"issue":"1","key":"951_CR104","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3233\/JAD-160725","volume":"56","author":"SW Brooks","year":"2017","unstructured":"Brooks SW, Dykes AC, Schreurs BG. A high-cholesterol diet increases 27-hydroxycholesterol and modifies estrogen receptor expression and neurodegeneration in rabbit hippocampus. J Alzheimers Dis. 2017;56(1):185\u201396. https:\/\/doi.org\/10.3233\/JAD-160725.","journal-title":"J Alzheimer\u2019s Disease"},{"issue":"6","key":"951_CR105","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1002\/glia.24348","volume":"71","author":"V Alanko","year":"2023","unstructured":"Alanko V, Gaminde-Blasco A, Quintela-L\u00f3pez T, Loera-Valencia R, Solomon A, Bj\u00f6rkhem I, et al. 27-hydroxycholesterol promotes oligodendrocyte maturation: implications for hypercholesterolemia-associated brain white matter changes. Glia. 2023;71(6):1414\u201328. https:\/\/doi.org\/10.1002\/glia.24348.","journal-title":"Glia"},{"issue":"3","key":"951_CR106","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1084\/jem.20160534","volume":"214","author":"MAM Ismail","year":"2017","unstructured":"Ismail MAM, Mateos L, Maioli S, Merino-Serrais P, Ali Z, Lodeiro M, et al. 27-hydroxycholesterol impairs neuronal glucose uptake through an IRAP\/GLUT4 system dysregulation. J Exp Med. 2017;214(3):699\u2013717. https:\/\/doi.org\/10.1084\/jem.20160534.","journal-title":"J Exp Med"},{"issue":"1","key":"951_CR107","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12974-020-01873-7","volume":"17","author":"Y Wang","year":"2020","unstructured":"Wang Y, An Y, Ma W, Yu H, Lu Y, Zhang X, et al. 27-hydroxycholesterol contributes to cognitive deficits in APP\/PS1 transgenic mice through microbiota dysbiosis and intestinal barrier dysfunction. J Neuroinflammation. 2020;17(1):199. https:\/\/doi.org\/10.1186\/s12974-020-01873-7.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"951_CR108","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12974-020-01869-3","volume":"17","author":"MY Wong","year":"2020","unstructured":"Wong MY, Lewis M, Doherty JJ, Shi Y, Cashikar AG, Amelianchik A, et al. 25-hydroxycholesterol amplifies microglial IL-1\u03b2 production in an apoE isoform-dependent manner. J Neuroinflammation. 2020;17(1):192. https:\/\/doi.org\/10.1186\/s12974-020-01869-3.","journal-title":"J Neuroinflammation"},{"issue":"4","key":"951_CR109","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1084\/jem.20232000","volume":"221","author":"D Toral-Rios","year":"2024","unstructured":"Toral-Rios D, Long JM, Ulrich JD, Yu J, Strickland MR, Han X, et al. Cholesterol 25-hydroxylase mediates neuroinflammation and neurodegeneration in a mouse model of tauopathy. J Exp Med. 2024;221(4):221. https:\/\/doi.org\/10.1084\/jem.20232000.","journal-title":"J Exp Med"},{"issue":"1","key":"951_CR110","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12974-024-03233-1","volume":"21","author":"J Romero","year":"2024","unstructured":"Romero J, Toral-Rios D, Yu J, Paul SM, Cashikar AG. 25-hydroxycholesterol promotes brain cytokine production and leukocyte infiltration in a mouse model of lipopolysaccharide-induced neuroinflammation. J Neuroinflammation. 2024;21(1):251. https:\/\/doi.org\/10.1186\/s12974-024-03233-1.","journal-title":"J Neuroinflammation"},{"key":"951_CR111","doi-asserted-by":"publisher","first-page":"853460","DOI":"10.3389\/fnut.2022.853460","volume":"9","author":"F Canzoneri","year":"2022","unstructured":"Canzoneri F, Leoni V, Rosso G, Risso D, Menta R, Poli G. Oxysterols as reliable markers of quality and safety in cholesterol-containing food ingredients and products. Front Nutr. 2022;9:853460. https:\/\/doi.org\/10.3389\/fnut.2022.853460.","journal-title":"Front Nutr"},{"issue":"8","key":"951_CR112","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/pcn.13706","volume":"78","author":"J Ha","year":"2024","unstructured":"Ha J, Kwon GE, Son Y, Jang SA, Cho SY, Park SJ, et al. Cholesterol profiling reveals 7\u03b2-hydroxycholesterol as a pathologically relevant peripheral biomarker of Alzheimer\u2019s disease. Psychiatry Clin Neurosci. 2024;78(8):473\u201381. https:\/\/doi.org\/10.1111\/pcn.13706.","journal-title":"Psychiatry Clin Neurosci"},{"issue":"20","key":"951_CR113","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/ijms242015288","volume":"24","author":"Y Son","year":"2023","unstructured":"Son Y, Yeo IJ, Hong JT, Eo SK, Lee D, Kim K. Side-chain immune oxysterols induce neuroinflammation by activating microglia. Int J Mol Sci. 2023;24(20):24. https:\/\/doi.org\/10.3390\/ijms242015288.","journal-title":"IJMS"},{"issue":"11","key":"951_CR114","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/mds.29577","volume":"38","author":"L Dai","year":"2023","unstructured":"Dai L, Wang J, Zhang X, Yan M, Zhou L, Zhang G, et al. 27-hydroxycholesterol drives the spread of \u03b1-synuclein pathology in Parkinson\u2019s disease. Mov Disord. 2023;38(11):2005\u201318. https:\/\/doi.org\/10.1002\/mds.29577.","journal-title":"Mov Disord"},{"issue":"3","key":"951_CR115","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/mds.27609","volume":"34","author":"X Huang","year":"2019","unstructured":"Huang X, Sterling NW, Du G, Sun D, Stetter C, Kong L, et al. Brain cholesterol metabolism and Parkinson\u2019s disease. Mov Disord. 2019;34(3):386\u201395. https:\/\/doi.org\/10.1002\/mds.27609.","journal-title":"Mov Disord"},{"issue":"3","key":"951_CR116","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1093\/brain\/awv384","volume":"139","author":"L Boussicault","year":"2016","unstructured":"Boussicault L, Alves S, Lamazi\u00e8re A, Planques A, Heck N, Moumn\u00e9 L, et al. CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington\u2019s disease. Brain. 2016;139(3):953\u201370. https:\/\/doi.org\/10.1093\/brain\/awv384.","journal-title":"Brain"},{"issue":"4","key":"951_CR117","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3233\/JHD-240030","volume":"13","author":"SM Gray","year":"2024","unstructured":"Gray SM, Dai J, Smith AC, Beckley JT, Rahmati N, Lewis MC, et al. Changes in 24(S)-hydroxycholesterol are associated with cognitive performance in early Huntington\u2019s disease: data from the TRACK and ENROLL HD cohorts. J Huntingtons Dis. 2024;13(4):449\u201365. https:\/\/doi.org\/10.3233\/JHD-240030.","journal-title":"J Huntingtons Dis"},{"key":"951_CR118","doi-asserted-by":"publisher","unstructured":"Maioli S, B\u00e5vner A, Ali Z, Heverin M, Ismail MAM, Puerta E, et al. Is it possible to improve memory function by upregulation of the cholesterol 24S-hydroxylase (CYP46A1) in the brain? PLoS ONE. 2013;8(7):e68534. https:\/\/doi.org\/10.1371\/journal.pone.0068534.","DOI":"10.1371\/journal.pone.0068534"},{"key":"951_CR119","doi-asserted-by":"publisher","first-page":"106387","DOI":"10.1016\/j.jsbmb.2023.106387","volume":"234","author":"J Goikolea","year":"2023","unstructured":"Goikolea J, Latorre-Leal M, Tsagkogianni C, Pikkupeura S, Gulyas B, Cedazo-Minguez A, et al. Different effects of CYP27A1 and CYP7B1 on cognitive function: two mouse models in comparison. The J Steroid Biochem Mol Biol. 2023;234:106387. https:\/\/doi.org\/10.1016\/j.jsbmb.2023.106387.","journal-title":"The J Steroid Biochem Mol Biol"},{"issue":"8","key":"951_CR120","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1073\/pnas.95.8.4089","volume":"95","author":"EE Baulieu","year":"1998","unstructured":"Baulieu EE, Robel P. Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) as neuroactive neurosteroids. Proc Natl Acad Sci USA. 1998;95(8):4089\u201391. https:\/\/doi.org\/10.1073\/pnas.95.8.4089.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"951_CR121","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00540-023-03291-4","volume":"38","author":"H Tateiwa","year":"2024","unstructured":"Tateiwa H, Evers AS. Neurosteroids and their potential as a safer class of general anesthetics. J Anesth. 2024;38(2):261\u201374. https:\/\/doi.org\/10.1007\/s00540-023-03291-4.","journal-title":"J Anesth"},{"key":"951_CR122","first-page":"830","volume-title":"Encyclopedia of psychopharmacology","author":"AL Morrow","year":"2010","unstructured":"Morrow AL, Porcu P. Neuroactive steroids. In: Stolerman IP, editor. Encyclopedia of psychopharmacology. Berlin, Heidelberg: Springer Berlin Heidelberg; 2010. p. 830\u201338."},{"issue":"3\u20134","key":"951_CR123","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1615\/CritRevNeurobiol.v15.i34.20","volume":"15","author":"DS Reddy","year":"2004","unstructured":"Reddy DS. Pharmacology of endogenous neuroactive steroids. Crit Rev Neurobiol. 2004;15(3\u20134):197\u2013234. https:\/\/doi.org\/10.1615\/CritRevNeurobiol.v15.i34.20.","journal-title":"Crit Rev Neurobiol"},{"key":"951_CR124","doi-asserted-by":"crossref","unstructured":"Reddy DS, Bakshi K. Neurosteroids: biosynthesis, molecular mechanisms, and neurophysiological functions in the human brain. In: Hormonal signaling in biology and medicine. Elsevier; 2020. p. 69\u201382.","DOI":"10.1016\/B978-0-12-813814-4.00004-3"},{"issue":"4753","key":"951_CR125","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1126\/science.2422758","volume":"232","author":"MD Majewska","year":"1986","unstructured":"Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science. 1986;232(4753):1004\u201307. https:\/\/doi.org\/10.1126\/science.2422758.","journal-title":"Science"},{"issue":"2\u20133","key":"951_CR126","first-page":"207","volume":"9","author":"KW Gee","year":"1995","unstructured":"Gee KW, McCauley LD, Lan NC. A putative receptor for neurosteroids on the GABAA receptor complex: the pharmacological properties and therapeutic potential of epalons. Crit Rev Neurobiol. 1995;9(2\u20133):207\u201327.","journal-title":"Crit Rev Neurobiol"},{"issue":"5","key":"951_CR127","doi-asserted-by":"publisher","first-page":"886","DOI":"10.2174\/1570159X19666211202150041","volume":"20","author":"L Wang","year":"2022","unstructured":"Wang L, Covey DF, Akk G, Evers AS. Neurosteroid modulation of GABAA \u200b receptor function by independent action at multiple specific binding sites. Curr Neuropharmacol. 2022;20(5):886\u201390. https:\/\/doi.org\/10.2174\/1570159X19666211202150041.","journal-title":"CN"},{"issue":"2","key":"951_CR128","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0006-3223(99)00217-6","volume":"47","author":"T Hillen","year":"2000","unstructured":"Hillen T, Lun A, Reischies FM, Borchelt M, Steinhagen-Thiessen E, Schaub RT. DHEA-S plasma levels and incidence of Alzheimer\u2019s disease. Biol Psychiatry. 2000;47(2):161\u201363. https:\/\/doi.org\/10.1016\/S0006-3223(99)00217-6.","journal-title":"Biol Psychiatry"},{"issue":"8662","key":"951_CR129","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/S0140-6736(89)90700-9","volume":"334","author":"T Sunderland","year":"1989","unstructured":"Sunderland T, Merril CR, Harrington MG, Lawlor BA, Molchan SE, Martinez R, et al. Reduced plasma dehydroepiandrosterone concentrations in Alzheimer\u2019s disease. Lancet. 1989;334(8662):570. https:\/\/doi.org\/10.1016\/S0140-6736(89)90700-9.","journal-title":"Lancet"},{"issue":"11","key":"951_CR130","doi-asserted-by":"publisher","first-page":"5138","DOI":"10.1210\/jc.2002-020878","volume":"87","author":"S Weill-Engerer","year":"2002","unstructured":"Weill-Engerer S, David JP, Sazdovitch V, Liere P, Eychenne B, Pianos A, et al. Neurosteroid quantification in human brain regions: comparison between Alzheimer\u2019s and nondemented patients. J Clin Endocr Metab. 2002;87(11):5138\u201343. https:\/\/doi.org\/10.1210\/jc.2002-020878.","journal-title":"J CLIN ENDOCR Metab"},{"issue":"23","key":"951_CR131","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1016\/j.lfs.2004.05.026","volume":"75","author":"SA Farr","year":"2004","unstructured":"Farr SA, Banks WA, Uezu K, Gaskin FS, Morley JE. DHEAS improves learning and memory in aged SAMP8 mice but not in diabetic mice. Life Sci. 2004;75(23):2775\u201385. https:\/\/doi.org\/10.1016\/j.lfs.2004.05.026.","journal-title":"Life Sci"},{"issue":"48","key":"951_CR132","doi-asserted-by":"publisher","first-page":"13357","DOI":"10.1523\/JNEUROSCI.2718-07.2007","volume":"27","author":"JC Carroll","year":"2007","unstructured":"Carroll JC, Rosario ER, Chang L, Stanczyk FZ, Oddo S, LaFerla FM, et al. Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J Neurosci. 2007;27(48):13357\u201365. https:\/\/doi.org\/10.1523\/JNEUROSCI.2718-07.2007.","journal-title":"J Neurosci"},{"issue":"1","key":"951_CR133","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41398-021-01266-1","volume":"11","author":"I Balan","year":"2021","unstructured":"Balan I, Aurelian L, Schleicher R, Boero G, O\u2019Buckley T, Morrow AL. Neurosteroid allopregnanolone (3\u03b1, 5\u03b1-THP) inhibits inflammatory signals induced by activated MyD88-dependent toll-like receptors. Transl Psychiatry. 2021;11(1):145. https:\/\/doi.org\/10.1038\/s41398-021-01266-1.","journal-title":"Transl Psychiatry"},{"issue":"7","key":"951_CR134","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/life14070860","volume":"14","author":"I Balan","year":"2024","unstructured":"Balan I, Grusca A, Ch\u00e9ry SL, Materia BR, O\u2019Buckley TK, Morrow AL. Neurosteroid [3\u03b1, 5\u03b1]-3-hydroxy-pregnan-20-one enhances the CX3CL1-CX3CR1 pathway in the brain of alcohol-preferring rats with sex-specificity. Life (Basel). 2024;14(7):14. https:\/\/doi.org\/10.3390\/life14070860.","journal-title":"Life (Basel)"},{"key":"951_CR135","doi-asserted-by":"publisher","first-page":"115785","DOI":"10.1016\/j.bbr.2025.115785","volume":"495","author":"B Tidke","year":"2025","unstructured":"Tidke B, Itekar S, Khobragade R, Vinchurney M, Trivedi R, Taksande B, et al. Therapeutic implications of allopregnanolone in Alzheimer\u2019s related depression. Behav Brain Res. 2025;495:115785. https:\/\/doi.org\/10.1016\/j.bbr.2025.115785.","journal-title":"Behavioural Brain Res"},{"key":"951_CR136","doi-asserted-by":"publisher","unstructured":"Raikes AC, Hernandez GD, Matthews DC, Lukic AS, Law M, Shi Y, et al. Exploratory imaging outcomes of a phase 1b\/2a clinical trial of allopregnanolone as a regenerative therapeutic for Alzheimer\u2019s disease: structural effects and functional connectivity outcomes. Alzheimer\u2019s Dement Transl Res Clin Interv. 2022;8(1):e12258. https:\/\/doi.org\/10.1002\/trc2.12258.","DOI":"10.1002\/trc2.12258"},{"key":"951_CR137","doi-asserted-by":"publisher","unstructured":"Hernandez GD, Solinsky CM, Mack WJ, Kono N, Rodgers KE, Wu CY, et al. Safety, tolerability, and pharmacokinetics of allopregnanolone as a regenerative therapeutic for Alzheimer\u2019s disease: a single and multiple ascending dose phase 1b\/2a clinical trial. Alzheimer\u2019s Dement Transl Res Clin Interv. 2020;6(1):e12107. https:\/\/doi.org\/10.1002\/trc2.12107.","DOI":"10.1002\/trc2.12107"},{"key":"951_CR138","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.pneurobio.2013.08.004","volume":"113","author":"RW Irwin","year":"2014","unstructured":"Irwin RW, Brinton RD. Allopregnanolone as regenerative therapeutic for Alzheimer\u2019s disease: translational development and clinical promise. Prog Neurobiol. 2014;113:40\u201355. https:\/\/doi.org\/10.1016\/j.pneurobio.2013.08.004.","journal-title":"Prog Neurobiol"},{"key":"951_CR139","doi-asserted-by":"publisher","first-page":"100502","DOI":"10.1016\/j.ynstr.2022.100502","volume":"21","author":"GD Hernandez","year":"2022","unstructured":"Hernandez GD, Brinton RD. Allopregnanolone: regenerative therapeutic to restore neurological health. Neurobiol Stress. 2022;21:100502. https:\/\/doi.org\/10.1016\/j.ynstr.2022.100502.","journal-title":"Neurobiol Stress"},{"issue":"3","key":"951_CR140","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s10072-003-0115-1","volume":"24","author":"di Michele F","year":"2003","unstructured":"di Michele F, Longone P, Romeo E, Lucchetti S, Brusa L, Pierantozzi M, et al. Decreased plasma and cerebrospinal fluid content of neuroactive steroids in Parkinson\u2019s disease. Neurol Sci. 2003;24(3):172\u201373. https:\/\/doi.org\/10.1007\/s10072-003-0115-1.","journal-title":"Neurol. Sci"},{"key":"951_CR141","doi-asserted-by":"crossref","unstructured":"Cavallieri F, Lucchi C, Grisanti S, Monfrini E, Fioravanti V, Toschi G, et al. Neurosteroid levels in GBA mutated and non-mutated Parkinson\u2019s disease: a possible factor influencing clinical phenotype? Biomolecules. 2024;14.","DOI":"10.20944\/preprints202407.1915.v1"},{"issue":"1","key":"951_CR142","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s12031-011-9570-y","volume":"46","author":"RC Melcangi","year":"2012","unstructured":"Melcangi RC, Caruso D, Levandis G, Abbiati F, Armentero MT, Blandini F. Modifications of neuroactive steroid levels in an experimental model of nigrostriatal degeneration: potential relevance to the pathophysiology of Parkinson\u2019s disease. J Mol Neurosci. 2012;46(1):177\u201383. https:\/\/doi.org\/10.1007\/s12031-011-9570-y.","journal-title":"J Mol Neurosci"},{"key":"951_CR143","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.bbr.2016.03.019","volume":"305","author":"A Nezhadi","year":"2016","unstructured":"Nezhadi A, Sheibani V, Esmaeilpour K, Shabani M, Esmaeili-Mahani S. Neurosteroid allopregnanolone attenuates cognitive dysfunctions in 6-OHDA-induced rat model of Parkinson\u2019s disease. Behav Brain Res. 2016;305:258\u201364. https:\/\/doi.org\/10.1016\/j.bbr.2016.03.019.","journal-title":"Behavioural Brain Res"},{"issue":"19","key":"951_CR144","doi-asserted-by":"publisher","first-page":"4706","DOI":"10.1523\/JNEUROSCI.4520-04.2005","volume":"25","author":"JM Wang","year":"2005","unstructured":"Wang JM, Johnston PB, Ball BG, Brinton RD. The neurosteroid allopregnanolone promotes proliferation of rodent and human neural progenitor cells and regulates cell-cycle gene and protein expression. J Neurosci. 2005;25(19):4706\u201318. https:\/\/doi.org\/10.1523\/JNEUROSCI.4520-04.2005.","journal-title":"J Neurosci"},{"key":"951_CR145","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.neuropharm.2017.02.007","volume":"117","author":"N Litim","year":"2017","unstructured":"Litim N, Morissette M, Di Paolo T. Effects of progesterone administered after MPTP on dopaminergic neurons of male mice. Neuropharmacology. 2017;117:209\u201318. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.02.007.","journal-title":"Neuropharmacology"},{"issue":"4","key":"951_CR146","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.pbb.2011.06.012","volume":"99","author":"S Casas","year":"2011","unstructured":"Casas S, Garc\u00eda S, Cabrera R, Nanfaro F, Escudero C, Yunes R. Progesterone prevents depression-like behavior in a model of Parkinson\u2019s disease induced by 6-hydroxydopamine in male rats. Pharmacol Biochem Behav. 2011;99(4):614\u201318. https:\/\/doi.org\/10.1016\/j.pbb.2011.06.012.","journal-title":"Pharmacol Biochem Behav"},{"key":"951_CR147","doi-asserted-by":"publisher","first-page":"114370","DOI":"10.1016\/j.expneurol.2023.114370","volume":"363","author":"S Corsi","year":"2023","unstructured":"Corsi S, Scheggi S, Pardu A, Braccagni G, Caruso D, Cioffi L, et al. Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson\u2019s disease. Exp Neurol. 2023;363:114370. https:\/\/doi.org\/10.1016\/j.expneurol.2023.114370.","journal-title":"Exp Neurol"},{"issue":"9","key":"951_CR148","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1002\/mds.30280","volume":"40","author":"M Bourque","year":"2025","unstructured":"Bourque M, Morissette M, Bortolato M, Frau R, Carta M, Di Paolo T. Pregnenolone reduces L-Dopa-induced dyskinesias in female parkinsonian monkeys. Mov Disord. 2025;40(9):1996\u20132001. https:\/\/doi.org\/10.1002\/mds.30280.","journal-title":"Mov Disord"},{"issue":"2","key":"951_CR149","first-page":"199","volume":"28","author":"M Markianos","year":"2007","unstructured":"Markianos M, Panas M, Kalfakis N, Vassilopoulos D. Plasma testosterone, dehydroepiandrosterone sulfate, and cortisol in female patients with Huntington\u2019s disease. Neuro Endocrinol Lett. 2007;28(2):199\u2013203.","journal-title":"Neuro Endocrinol Lett"},{"issue":"2","key":"951_CR150","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.neuint.2011.11.015","volume":"60","author":"HN Kim","year":"2012","unstructured":"Kim HN, Lee SJ, Koh JY. The neurosteroids, allopregnanolone and progesterone, induce autophagy in cultured astrocytes. Neurochem Int. 2012;60(2):125\u201333. https:\/\/doi.org\/10.1016\/j.neuint.2011.11.015.","journal-title":"Neurochemistry Int"},{"key":"951_CR151","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejphar.2013.11.036","volume":"723","author":"P Kumar","year":"2014","unstructured":"Kumar P, Kumar P, Khan A, Deshmukh R, Lal Sharma P. Role of neurosteroids in experimental 3-nitropropionic acid induced neurotoxicity in rats. Eur J Pharmacol. 2014;723:38\u201345. https:\/\/doi.org\/10.1016\/j.ejphar.2013.11.036.","journal-title":"Eur J Pharmacol"},{"issue":"7465","key":"951_CR152","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nature12481","volume":"501","author":"M Jucker","year":"2013","unstructured":"Jucker M, Walker LC. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature. 2013;501(7465):45\u201351. https:\/\/doi.org\/10.1038\/nature12481.","journal-title":"Nature"},{"issue":"6248","key":"951_CR153","doi-asserted-by":"publisher","first-page":"1255555","DOI":"10.1126\/science.1255555","volume":"349","author":"M Goedert","year":"2015","unstructured":"Goedert M. Alzheimer\u2019s and Parkinson\u2019s diseases: the prion concept in relation to assembled A\u03b2, tau, and \u03b1-synuclein. Science. 2015;349(6248):1255555. https:\/\/doi.org\/10.1126\/science.1255555.","journal-title":"Science"},{"issue":"1","key":"951_CR154","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41514-021-00064-9","volume":"7","author":"VR Varma","year":"2021","unstructured":"Varma VR, B\u00fc\u015fra L\u00fcleci H, Oommen AM, Varma S, Blackshear CT, Griswold ME, et al. Abnormal brain cholesterol homeostasis in Alzheimer\u2019s disease\u2014a targeted metabolomic and transcriptomic study. Npj Aging Mech Dis. 2021;7(1):11. https:\/\/doi.org\/10.1038\/s41514-021-00064-9.","journal-title":"Npj Aging Mech Dis"},{"issue":"5","key":"951_CR155","doi-asserted-by":"publisher","first-page":"740","DOI":"10.3390\/antiox10050740","volume":"10","author":"P Gamba","year":"2021","unstructured":"Gamba P, Giannelli S, Staurenghi E, Testa G, Sottero B, Biasi F, et al. The controversial role of 24-S-hydroxycholesterol in Alzheimer\u2019s disease. Antioxidants. 2021;10(5):740. https:\/\/doi.org\/10.3390\/antiox10050740.","journal-title":"Antioxidants"},{"issue":"4","key":"951_CR156","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/bpa.12698","volume":"29","author":"X Zhang","year":"2019","unstructured":"Zhang X, Xi Y, Yu H, An Y, Wang Y, Tao L, et al. 27-hydroxycholesterol promotes A\u03b2 accumulation via altering A\u03b2 metabolism in mild cognitive impairment patients and APP\/PS1 mice. Brain Pathol. 2019;29(4):558\u201373. https:\/\/doi.org\/10.1111\/bpa.12698.","journal-title":"Brain Pathol"},{"issue":"1","key":"951_CR157","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40478-022-01338-3","volume":"10","author":"X Bai","year":"2022","unstructured":"Bai X, Mai M, Yao K, Zhang M, Huang Y, Zhang W, et al. The role of DHCR24 in the pathogenesis of AD: re-cognition of the relationship between cholesterol and AD pathogenesis. Acta Neuropathol Commun. 2022;10(1):35. https:\/\/doi.org\/10.1186\/s40478-022-01338-3.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"951_CR158","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/s41467-022-28769-9","volume":"13","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Hu D, Wang R, Sun X, Ropelewski P, Hubler Z, et al. ATAD3A oligomerization promotes neuropathology and cognitive deficits in Alzheimer\u2019s disease models. Nat Commun. 2022;13(1):1121. https:\/\/doi.org\/10.1038\/s41467-022-28769-9.","journal-title":"Nat Commun"},{"issue":"1","key":"951_CR159","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","volume":"34","author":"RJ O\u2019brien","year":"2011","unstructured":"O\u2019brien RJ, Wong PC. Amyloid precursor protein processing and Alzheimer\u2019s disease. Annu Rev Neurosci. 2011;34(1):185\u2013204. https:\/\/doi.org\/10.1146\/annurev-neuro-061010-113613.","journal-title":"Annu. Rev. Neurosci"},{"issue":"6700","key":"951_CR160","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1126\/science.adn5820","volume":"384","author":"X Guo","year":"2024","unstructured":"Guo X, Li H, Yan C, Lei J, Zhou R, Shi Y. Molecular mechanism of substrate recognition and cleavage by human \u03b3-secretase. Science. 2024;384(6700):1091\u201395. https:\/\/doi.org\/10.1126\/science.adn5820.","journal-title":"Science"},{"issue":"6085","key":"951_CR161","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1126\/science.1219988","volume":"336","author":"PJ Barrett","year":"2012","unstructured":"Barrett PJ, Song Y, Van Horn WD, Hustedt EJ, Schafer JM, Hadziselimovic A, et al. The amyloid precursor protein has a flexible transmembrane domain and binds cholesterol. Science. 2012;336(6085):1168\u201371. https:\/\/doi.org\/10.1126\/science.1219988.","journal-title":"Science"},{"issue":"10","key":"951_CR162","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1021\/acs.jcim.7b00431","volume":"57","author":"C Lockhart","year":"2017","unstructured":"Lockhart C, Klimov DK. Cholesterol changes the mechanisms of A\u03b2 peptide binding to the DMPC bilayer. J Chem Inf Model. 2017;57(10):2554\u201365. https:\/\/doi.org\/10.1021\/acs.jcim.7b00431.","journal-title":"J Chem Inf Model"},{"key":"951_CR163","doi-asserted-by":"publisher","first-page":"937056","DOI":"10.3389\/fnmol.2022.937056","volume":"15","author":"V Rudajev","year":"2022","unstructured":"Rudajev V, Novotny J. Cholesterol as a key player in amyloid \u03b2-mediated toxicity in Alzheimer\u2019s disease. Front Mol Neurosci. 2022;15:937056. https:\/\/doi.org\/10.3389\/fnmol.2022.937056.","journal-title":"Front Mol Neurosci"},{"key":"951_CR164","doi-asserted-by":"publisher","unstructured":"Wang H, Kulas JA, Wang C, Holtzman DM, Ferris HA, Hansen SB. Regulation of beta-amyloid production in neurons by astrocyte-derived cholesterol. Proc Natl Acad Sci USA. 2021;118(33):e2102191118. https:\/\/doi.org\/10.1073\/pnas.2102191118.","DOI":"10.1073\/pnas.2102191118"},{"key":"951_CR165","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3389\/fphys.2012.00189","volume":"3","author":"DA Hicks","year":"2012","unstructured":"Hicks DA, Nalivaeva NN, Turner AJ. Lipid rafts and Alzheimer\u2019s disease: protein-lipid interactions and perturbation of signaling. Front Physiol. 2012;3:189. https:\/\/doi.org\/10.3389\/fphys.2012.00189.","journal-title":"Front Physio"},{"issue":"5","key":"951_CR166","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jlr.2023.100367","volume":"64","author":"Y Huang","year":"2023","unstructured":"Huang Y, Zhang W, Guo X, Zhang Y, Wu J, Zu H. Cellular cholesterol loss by DHCR24 knockdown leads to A\u03b2 production by changing APP intracellular localization. J Lipid Res. 2023;64(5):64. https:\/\/doi.org\/10.1016\/j.jlr.2023.100367.","journal-title":"J Lipid Res"},{"key":"951_CR167","doi-asserted-by":"publisher","unstructured":"Montesinos J, Pera M, Larrea D, Guardia-Laguarta C, Agrawal RR, Velasco KR, et al. The Alzheimer\u2019s disease-associated C99 fragment of APP regulates cellular cholesterol trafficking. EMBO J. 2020;39(20):e103791. https:\/\/doi.org\/10.15252\/embj.2019103791.","DOI":"10.15252\/embj.2019103791"},{"issue":"6","key":"951_CR168","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1080\/15548627.2021.1920814","volume":"17","author":"V Roca-Agujetas","year":"2021","unstructured":"Roca-Agujetas V, de Dios C, Abadin X, Colell A. Upregulation of brain cholesterol levels inhibits mitophagy in Alzheimer disease. Autophagy. 2021;17(6):1555\u201357. https:\/\/doi.org\/10.1080\/15548627.2021.1920814.","journal-title":"Autophagy"},{"issue":"10","key":"951_CR169","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1093\/jnen\/nlw067","volume":"75","author":"NM Heinsinger","year":"2016","unstructured":"Heinsinger NM, Gachechiladze MA, Rebeck GW. Apolipoprotein E genotype affects size of ApoE complexes in cerebrospinal fluid. J Neuropathol Exp Neurol. 2016;75(10):918\u201324. https:\/\/doi.org\/10.1093\/jnen\/nlw067.","journal-title":"J Neuropathol Exp Neurol"},{"key":"951_CR170","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3389\/fnagi.2020.00150","volume":"12","author":"HN Yassine","year":"2020","unstructured":"Yassine HN, Finch CE. APOE alleles and diet in brain aging and Alzheimer\u2019s disease. Front Aging Neurosci. 2020;12:150. https:\/\/doi.org\/10.3389\/fnagi.2020.00150.","journal-title":"Front Aging Neurosci"},{"issue":"20","key":"951_CR171","doi-asserted-by":"publisher","first-page":"17536","DOI":"10.1074\/jbc.M111.225532","volume":"286","author":"K Nishitsuji","year":"2011","unstructured":"Nishitsuji K, Hosono T, Nakamura T, Bu G, Michikawa M. Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in vitro blood-brain barrier model. J Biol Chem. 2011;286(20):17536\u201342. https:\/\/doi.org\/10.1074\/jbc.M111.225532.","journal-title":"J Biol Chem"},{"issue":"7399","key":"951_CR172","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nature11087","volume":"485","author":"RD Bell","year":"2012","unstructured":"Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, Wu Z, et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature. 2012;485(7399):512\u201316. https:\/\/doi.org\/10.1038\/nature11087.","journal-title":"Nature"},{"issue":"7806","key":"951_CR173","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","volume":"581","author":"A Montagne","year":"2020","unstructured":"Montagne A, Nation DA, Sagare AP, Barisano G, Sweeney MD, Chakhoyan A, et al. APOE4 leads to blood\u2013brain barrier dysfunction predicting cognitive decline. Nature. 2020;581(7806):71\u201376. https:\/\/doi.org\/10.1038\/s41586-020-2247-3.","journal-title":"Nature"},{"issue":"2","key":"951_CR174","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41422-022-00759-y","volume":"33","author":"J Zhou","year":"2023","unstructured":"Zhou J, Wang Y, Huang G, Yang M, Zhu Y, Jin C, et al. LilrB3 is a putative cell surface receptor of APOE4. Cell Res. 2023;33(2):116\u201330. https:\/\/doi.org\/10.1038\/s41422-022-00759-y.","journal-title":"Cell Res"},{"issue":"8","key":"951_CR175","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1097\/NEN.0b013e3181e77ed9","volume":"69","author":"HJ Huttunen","year":"2010","unstructured":"Huttunen HJ, Havas D, Peach C, Barren C, Duller S, Xia W, et al. The acyl-coenzyme A: cholesterol acyltransferase inhibitor CI-1011 reverses diffuse brain amyloid pathology in aged amyloid precursor protein transgenic mice. J Neuropathol Exp Neurol. 2010;69(8):777\u201388. https:\/\/doi.org\/10.1097\/NEN.0b013e3181e77ed9.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"951_CR176","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1194\/jlr.M300320-JLR200","volume":"45","author":"M Heverin","year":"2004","unstructured":"Heverin M, Bogdanovic N, L\u00fctjohann D, Bayer T, Pikuleva I, Bretillon L, et al. Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer\u2019s disease. J Lipid Res. 2004;45(1):186\u201393. https:\/\/doi.org\/10.1194\/jlr.M300320-JLR200.","journal-title":"J Lipid Res"},{"issue":"6","key":"951_CR177","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1474-4422(13)70090-5","volume":"12","author":"MG Spillantini","year":"2013","unstructured":"Spillantini MG, Goedert M. Tau pathology and neurodegeneration. Lancet Neurol. 2013;12(6):609\u201322. https:\/\/doi.org\/10.1016\/S1474-4422(13)70090-5.","journal-title":"The Lancet Neurol"},{"issue":"3","key":"951_CR178","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41591-020-0762-2","volume":"26","author":"EH Thijssen","year":"2020","unstructured":"Thijssen EH, La Joie R, Wolf A, Strom A, Wang P, Iaccarino L, et al. Diagnostic value of plasma phosphorylated tau181 in Alzheimer\u2019s disease and frontotemporal lobar degeneration. Nat Med. 2020;26(3):387\u201397. https:\/\/doi.org\/10.1038\/s41591-020-0762-2.","journal-title":"Nat Med (N Y, NY, U S)"},{"issue":"12","key":"951_CR179","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1093\/clinchem\/hvac149","volume":"68","author":"Z Xiao","year":"2022","unstructured":"Xiao Z, Wu W, Ma X, Liang X, Lu J, Zheng L, et al. Plasma A\u03b242\/A\u03b240 and p-tau181 predict long-term clinical progression in a cohort with amnestic mild cognitive impairment. Clin Chem. 2022;68(12):1552\u201363. https:\/\/doi.org\/10.1093\/clinchem\/hvac149.","journal-title":"Clin Chem"},{"key":"951_CR180","unstructured":"Lan G, Wang M, Gonzalez-Ortiz F, Zhang L, Li A, Li B, et al. Comprehensive evaluation of plasma Tau biomarkers for detecting and monitoring Alzheimer\u2019s disease in a multicenter and multiethnic aging population. Nat Aging. 2025;1\u201318."},{"issue":"6","key":"951_CR181","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.lanhl.2025.100717","volume":"6","author":"MA Heiskanen","year":"2025","unstructured":"Heiskanen MA, Mykk\u00e4nen J, Pahkala K, Juonala M, K\u00e4h\u00f6nen M, Lehtim\u00e4ki T, et al. Factors related to blood-based biomarkers for neurodegenerative diseases and their intergenerational associations in the young finns study: a cohort study. Lancet Healthy Longev. 2025;6(6):6. https:\/\/doi.org\/10.1016\/j.lanhl.2025.100717.","journal-title":"LancetThe Lancet Healthy Longevity"},{"key":"951_CR182","doi-asserted-by":"publisher","unstructured":"Sim\u00f5es-Pires EN, Torrente D, Singh P, Strickland S, Norris EH. Synergistic effects of the A\u03b2\/fibrinogen complex on synaptotoxicity, neuroinflammation, and blood\u2013brain barrier damage in Alzheimer\u2019s disease models. Alzheimers Dementia. 2025;21(5):e70119. https:\/\/doi.org\/10.1002\/alz.70119.","DOI":"10.1002\/alz.70119"},{"issue":"1","key":"951_CR183","doi-asserted-by":"publisher","first-page":"4634","DOI":"10.1038\/s41467-021-24900-4","volume":"12","author":"MP Sch\u00fctzmann","year":"2021","unstructured":"Sch\u00fctzmann MP, Hasecke F, Bachmann S, Zielinski M, H\u00e4nsch S, Schr\u00f6der GF, et al. Endo-lysosomal A\u03b2 concentration and pH trigger formation of A\u03b2 oligomers that potently induce tau missorting. Nat Commun. 2021;12(1):4634. https:\/\/doi.org\/10.1038\/s41467-021-24900-4.","journal-title":"Nat Commun"},{"issue":"1","key":"951_CR184","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41392-023-01601-6","volume":"8","author":"Z Tu","year":"2023","unstructured":"Tu Z, Yan S, Han B, Li C, Liang W, Lin Y, et al. Tauopathy promotes spinal cord-dependent production of toxic amyloid-beta in transgenic monkeys. Sig Transduct Target Ther. 2023;8(1):358. https:\/\/doi.org\/10.1038\/s41392-023-01601-6.","journal-title":"Sig Transduct Target Ther"},{"issue":"9","key":"951_CR185","doi-asserted-by":"publisher","first-page":"5856","DOI":"10.1007\/s12035-022-02945-w","volume":"59","author":"M Mai","year":"2022","unstructured":"Mai M, Guo X, Huang Y, Zhang W, Xu Y, Zhang Y, et al. DHCR24 knockdown induces tau hyperphosphorylation at Thr181, Ser199, Ser262, and Ser396 sites via activation of the lipid raft-dependent Ras\/MEK\/ERK signaling pathway in C8D1A astrocytes. Mol Neurobiol. 2022;59(9):5856\u201373. https:\/\/doi.org\/10.1007\/s12035-022-02945-w.","journal-title":"Mol Neurobiol"},{"key":"951_CR186","doi-asserted-by":"publisher","first-page":"109016","DOI":"10.1016\/j.jnutbio.2022.109016","volume":"106","author":"T Wang","year":"2022","unstructured":"Wang T, Zhang X, Wang Y, Liu W, Wang L, Hao L, et al. High cholesterol and 27-hydroxycholesterol contribute to phosphorylation of tau protein by impairing autophagy causing learning and memory impairment in C57BL\/6J mice. J Nutr Biochem. 2022;106:109016. https:\/\/doi.org\/10.1016\/j.jnutbio.2022.109016.","journal-title":"The J Nutritional Biochem"},{"issue":"3","key":"951_CR187","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.stem.2018.12.013","volume":"24","author":"van der Kant R","year":"2019","unstructured":"van der Kant R, Langness VF, Herrera CM, Williams DA, Fong LK, Leestemaker Y, et al. Cholesterol metabolism is a druggable axis that independently regulates tau and amyloid-\u03b2 in iPSC-derived Alzheimer\u2019s disease neurons. Cell Stem Cell. 2019;24(3):363\u201375. e9. https:\/\/doi.org\/10.1016\/j.stem.2018.12.013.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"951_CR188","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1056\/NEJMoa2415820","volume":"393","author":"SJ Nicholls","year":"2025","unstructured":"Nicholls SJ, Nelson AJ, Ditmarsch M, Kastelein JJP, Ballantyne CM, Ray KK, et al. Safety and efficacy of obicetrapib in patients at high cardiovascular risk. N Engl J Med. 2025;393(1):51\u201361. https:\/\/doi.org\/10.1056\/NEJMoa2415820.","journal-title":"N Engl J Med"},{"key":"951_CR189","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.neuropharm.2017.06.026","volume":"123","author":"N Mast","year":"2017","unstructured":"Mast N, Saadane A, Valencia-Olvera A, Constans J, Maxfield E, Arakawa H, et al. Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer\u2019s disease. Neuropharmacology. 2017;123:465\u201376. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.06.026.","journal-title":"Neuropharmacology"},{"issue":"3","key":"951_CR190","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.neuron.2023.10.023","volume":"112","author":"A Litvinchuk","year":"2024","unstructured":"Litvinchuk A, Suh JH, Guo JL, Lin K, Davis SS, Bien-Ly N, et al. Amelioration of tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist. Neuron. 2024;112(3):384\u2013403. e8. https:\/\/doi.org\/10.1016\/j.neuron.2023.10.023.","journal-title":"Neuron"},{"issue":"4","key":"951_CR191","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11064-025-04463-2","volume":"50","author":"SEV Richards","year":"2025","unstructured":"Richards SEV, Yang M, Deik AA, Ricq EL. APOE genotype impacts polyunsaturated Neutral lipid storage and ferroptosis vulnerability in astrocytes. Neurochem Res. 2025;50(4):211. https:\/\/doi.org\/10.1007\/s11064-025-04463-2.","journal-title":"Neurochem Res"},{"key":"951_CR192","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2016.01.055","volume":"226","author":"L Yao","year":"2016","unstructured":"Yao L, Gu X, Song Q, Wang X, Huang M, Hu M, et al. Nanoformulated alpha-mangostin ameliorates Alzheimer\u2019s disease neuropathology by elevating LDLR expression and accelerating amyloid-beta clearance. J Control Release. 2016;226:1\u201314. https:\/\/doi.org\/10.1016\/j.jconrel.2016.01.055.","journal-title":"J Control Release"},{"issue":"11","key":"951_CR193","doi-asserted-by":"publisher","first-page":"3819","DOI":"10.1096\/fj.09-134999","volume":"23","author":"HJ Huttunen","year":"2009","unstructured":"Huttunen HJ, Peach C, Bhattacharyya R, Barren C, Pettingell W, Hutter-Paier B, et al. Inhibition of acyl-coenzyme A: cholesterol acyltransferase modulates amyloid precursor protein trafficking in the early secretory pathway. FASEB J. 2009;23(11):3819. https:\/\/doi.org\/10.1096\/fj.09-134999.","journal-title":"Faseb J"},{"issue":"10423","key":"951_CR194","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","volume":"403","author":"Y Ben-Shlomo","year":"2024","unstructured":"Ben-Shlomo Y, Darweesh S, Llibre-Guerra J, Marras C, San Luciano M, Tanner C. The epidemiology of Parkinson\u2019s disease. Lancet. 2024;403(10423):283\u201392. https:\/\/doi.org\/10.1016\/S0140-6736(23)01419-8.","journal-title":"Lancet"},{"key":"951_CR195","doi-asserted-by":"publisher","unstructured":"Ma DF, Zhang S, Xu SY, Huang Z, Tao Y, Chen F, et al. Self-limiting multimerization of \u03b1-synuclein on membrane and its implication in Parkinson\u2019s diseases. Sci Adv. 2024;10(41):eado 4893. https:\/\/doi.org\/10.1126\/sciadv.ado4893.","DOI":"10.1126\/sciadv.ado4893"},{"issue":"10","key":"951_CR196","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.bbapap.2019.03.001","volume":"1867","author":"S Mehra","year":"2019","unstructured":"Mehra S, Sahay S, Maji SK. \u03b1-synuclein misfolding and aggregation: implications in Parkinson\u2019s disease pathogenesis. Biochim Biophys Acta Proteins Proteom. 2019;1867(10):890\u2013908. https:\/\/doi.org\/10.1016\/j.bbapap.2019.03.001.","journal-title":"Biochim Et Biophys Acta (BBA) - Proteins Proteomics"},{"issue":"3","key":"951_CR197","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.tins.2024.01.002","volume":"47","author":"J Wang","year":"2024","unstructured":"Wang J, Dai L, Chen S, Zhang Z, Fang X, Zhang Z. Protein\u2013protein interactions regulating \u03b1-synuclein pathology. Trends Neurosci. 2024;47(3):209\u201326. https:\/\/doi.org\/10.1016\/j.tins.2024.01.002.","journal-title":"Trends Neurosciences"},{"issue":"1","key":"951_CR198","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.1038\/s41467-023-39060-w","volume":"14","author":"AM Schonhoff","year":"2023","unstructured":"Schonhoff AM, Figge DA, Williams GP, Jurkuvenaite A, Gallups NJ, Childers GM, et al. Border-associated macrophages mediate the neuroinflammatory response in an alpha-synuclein model of Parkinson disease. Nat Commun. 2023;14(1):3754. https:\/\/doi.org\/10.1038\/s41467-023-39060-w.","journal-title":"Nat Commun"},{"issue":"9","key":"951_CR199","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1021\/acs.jpcb.2c08077","volume":"127","author":"Z Qi","year":"2023","unstructured":"Qi Z, Wan M, Zhang J, Li Z. Influence of cholesterol on the membrane binding and conformation of \u03b1-synuclein. J Phys Chem. B. 2023;127(9):1956\u201364. https:\/\/doi.org\/10.1021\/acs.jpcb.2c08077.","journal-title":"The J Phys Chem. B"},{"issue":"30","key":"951_CR200","doi-asserted-by":"publisher","first-page":"6715","DOI":"10.1523\/JNEUROSCI.1594-04.2004","volume":"24","author":"DL Fortin","year":"2004","unstructured":"Fortin DL, Troyer MD, Nakamura K, Kubo S, Anthony MD, Edwards RH. Lipid rafts mediate the synaptic localization of \u03b1-synuclein. J Neurosci. 2004;24(30):6715\u201323. https:\/\/doi.org\/10.1523\/JNEUROSCI.1594-04.2004.","journal-title":"J Neurosci"},{"issue":"5","key":"951_CR201","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1002\/mds.28396","volume":"36","author":"P Garc\u00eda-Sanz","year":"2021","unstructured":"Garc\u00eda-Sanz P, Mfga J, Moratalla R. The role of cholesterol in \u03b1-synuclein and Lewy body pathology in GBA1 Parkinson\u2019s disease. Mov Disord. 2021;36(5):1070\u201385. https:\/\/doi.org\/10.1002\/mds.28396.","journal-title":"Mov Disord"},{"issue":"6","key":"951_CR202","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1111\/febs.15551","volume":"288","author":"M Jakubec","year":"2021","unstructured":"Jakubec M, Bari\u00e5s E, Furse S, Govasli ML, George V, Turcu D, et al. Cholesterol-containing lipid nanodiscs promote an \u03b1-synuclein binding mode that accelerates oligomerization. FEBS J. 2021;288(6):1887\u2013905. https:\/\/doi.org\/10.1111\/febs.15551.","journal-title":"The FEBS J"},{"issue":"40","key":"951_CR203","doi-asserted-by":"publisher","first-page":"11099","DOI":"10.1021\/acs.jpcb.1c03533","volume":"125","author":"A Mahapatra","year":"2021","unstructured":"Mahapatra A, Mandal N, Chattopadhyay K. Cholesterol in synaptic vesicle membranes regulates the vesicle-binding, function, and aggregation of \u03b1-synuclein. J Phys Chem. B. 2021;125(40):11099\u2013111. https:\/\/doi.org\/10.1021\/acs.jpcb.1c03533.","journal-title":"The J Phys Chem. B"},{"issue":"7","key":"951_CR204","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41419-023-05977-9","volume":"14","author":"JO Min","year":"2023","unstructured":"Min JO, Ho HA, Lee W, Jung BC, Park SJ, Kim S, et al. Statins suppress cell-to-cell propagation of \u03b1-synuclein by lowering cholesterol. Cell Death Dis. 2023;14(7):474. https:\/\/doi.org\/10.1038\/s41419-023-05977-9.","journal-title":"Cell Death Dis"},{"issue":"40","key":"951_CR205","doi-asserted-by":"publisher","first-page":"29739","DOI":"10.1074\/jbc.M600933200","volume":"281","author":"JP Anderson","year":"2006","unstructured":"Anderson JP, Walker DE, Goldstein JM, de Laat R, Banducci K, Caccavello RJ, et al. Phosphorylation of Ser129 is the dominant pathological modification of \u03b1-synuclein in familial and sporadic Lewy body disease. J Biol Chem. 2006;281(40):29739\u201352. https:\/\/doi.org\/10.1074\/jbc.M600933200.","journal-title":"J Biol Chem"},{"issue":"5","key":"951_CR206","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/NEN.0b013e3186fc995","volume":"67","author":"EA Waxman","year":"2008","unstructured":"Waxman EA, Giasson BI. Specificity and regulation of casein kinase-mediated phosphorylation of \u03b1-synuclein. J Neuropathol Exp Neurol. 2008;67(5):402\u201316. https:\/\/doi.org\/10.1097\/NEN.0b013e3186fc995.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"24","key":"951_CR207","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.1016\/j.neuron.2023.11.020","volume":"111","author":"LA Parra-Rivas","year":"2023","unstructured":"Parra-Rivas LA, Madhivanan K, Aulston BD, Wang L, Prakashchand DD, Boyer NP, et al. Serine-129 phosphorylation of \u03b1-synuclein is an activity-dependent trigger for physiologic protein-protein interactions and synaptic function. Neuron. 2023;111(24):4006\u201323.e10. https:\/\/doi.org\/10.1016\/j.neuron.2023.11.020.","journal-title":"Neuron"},{"issue":"9","key":"951_CR208","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1021\/ar0500766","volume":"39","author":"J Bieschke","year":"2006","unstructured":"Bieschke J, Zhang Q, Bosco DA, Lerner RA, Powers ET, Wentworth P Jr, et al. Small molecule oxidation products trigger disease-associated protein misfolding. Acc Chem Res. 2006;39(9):611\u201319. https:\/\/doi.org\/10.1021\/ar0500766.","journal-title":"Acc Chem Res"},{"issue":"1","key":"951_CR209","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1478-811X-2-2","volume":"2","author":"H Gir\u00e3o","year":"2004","unstructured":"Gir\u00e3o H, Catarino S, Pereira P. 7-ketocholesterol modulates intercellular communication through gap-junction in bovine lens epithelial cells. Cell Commun Signal. 2004;2(1):2. https:\/\/doi.org\/10.1186\/1478-811X-2-2.","journal-title":"Cell Commun Signal"},{"key":"951_CR210","doi-asserted-by":"publisher","first-page":"101324","DOI":"10.1016\/j.arr.2021.101324","volume":"68","author":"T Nury","year":"2021","unstructured":"Nury T, Yammine A, Ghzaiel I, Sassi K, Zarrouk A, Brahmi F, et al. Attenuation of 7-ketocholesterol- and 7\u03b2-hydroxycholesterol-induced oxiapoptophagy by nutrients, synthetic molecules and oils: potential for the prevention of age-related diseases. Ageing Res Rev. 2021;68:101324. https:\/\/doi.org\/10.1016\/j.arr.2021.101324.","journal-title":"Ageing Res Rev"},{"issue":"12","key":"951_CR211","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1161\/01.ATV.0000146266.65820.a1","volume":"24","author":"W Martinet","year":"2004","unstructured":"Martinet W, De Bie M, Schrijvers DM, De Meyer GRY, Herman AG, Kockx MM. 7-ketocholesterol induces protein ubiquitination, myelin figure formation, and light chain 3 processing in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2004;24(12):2296\u2013301. https:\/\/doi.org\/10.1161\/01.ATV.0000146266.65820.a1.","journal-title":"ATVB"},{"issue":"10","key":"951_CR212","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41582-023-00873-4","volume":"19","author":"L Kiani","year":"2023","unstructured":"Kiani L. 27-hydroxycholesterol propagates \u03b1-synuclein pathology in Parkinson disease. Nat Rev Neurol. 2023;19(10):573. https:\/\/doi.org\/10.1038\/s41582-023-00873-4.","journal-title":"Nat Rev Neurol"},{"key":"951_CR213","doi-asserted-by":"publisher","unstructured":"Dai L, Wang J, Meng L, Zhang X, Xiao T, Deng M, et al. The cholesterol 24-hydroxylase CYP46A1 promotes \u03b1-synuclein pathology in Parkinson\u2019s disease. PLoS Biol. 2025;23(2):e3002974. https:\/\/doi.org\/10.1371\/journal.pbio.3002974.","DOI":"10.1371\/journal.pbio.3002974"},{"issue":"43","key":"951_CR214","doi-asserted-by":"publisher","first-page":"15970","DOI":"10.1021\/ja405993r","volume":"135","author":"Z Jiang","year":"2013","unstructured":"Jiang Z, de Messieres M, Lee JC. Membrane remodeling by \u03b1-synuclein and effects on amyloid formation. J Am Chem Soc. 2013;135(43):15970\u201373. https:\/\/doi.org\/10.1021\/ja405993r.","journal-title":"J Am Chem Soc"},{"issue":"28","key":"951_CR215","doi-asserted-by":"publisher","first-page":"11195","DOI":"10.1074\/jbc.RA118.002780","volume":"293","author":"EI O\u2019Leary","year":"2018","unstructured":"O\u2019Leary EI, Jiang Z, Strub MP, Lee JC. Effects of phosphatidylcholine membrane fluidity on the conformation and aggregation of N-terminally acetylated \u03b1-synuclein. J Biol Chem. 2018;293(28):11195\u2013205. https:\/\/doi.org\/10.1074\/jbc.RA118.002780.","journal-title":"J Biol Chem"},{"issue":"529","key":"951_CR216","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1126\/scitranslmed.aay3069","volume":"12","author":"AA Davis","year":"2020","unstructured":"Davis AA, Inman CE, Wargel ZM, Dube U, Freeberg BM, Galluppi A, et al. APOE genotype regulates pathology and disease progression in synucleinopathy. Sci Transl Med. 2020;12(529):12. https:\/\/doi.org\/10.1126\/scitranslmed.aay3069.","journal-title":"Sci Transl Med"},{"issue":"529","key":"951_CR217","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1126\/scitranslmed.aay1809","volume":"12","author":"N Zhao","year":"2020","unstructured":"Zhao N, Attrebi ON, Ren Y, Qiao W, Sonustun B, Martens YA, et al. APOE4 exacerbates \u03b1-synuclein pathology and related toxicity independent of amyloid. Sci Transl Med. 2020;12(529):12. https:\/\/doi.org\/10.1126\/scitranslmed.aay1809.","journal-title":"Sci Transl Med"},{"issue":"20","key":"951_CR218","doi-asserted-by":"publisher","first-page":"20387","DOI":"10.1021\/acsnano.3c06606","volume":"17","author":"SM McClain","year":"2023","unstructured":"McClain SM, Milchberg MH, Rienstra CM, Murphy CJ. Biologically representative lipid-coated gold nanoparticles and phospholipid vesicles for the study of alpha-synuclein\/membrane interactions. ACS Nano. 2023;17(20):20387\u2013401. https:\/\/doi.org\/10.1021\/acsnano.3c06606.","journal-title":"ACS Nano"},{"key":"951_CR219","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fnins.2020.00018","volume":"14","author":"WK Man","year":"2020","unstructured":"Man WK, De Simone A, Barritt JD, Vendruscolo M, Dobson CM, Fusco G. A role of cholesterol in modulating the binding of \u03b1-synuclein to synaptic-like vesicles. Front Neurosci. 2020;14:18. https:\/\/doi.org\/10.3389\/fnins.2020.00018.","journal-title":"Front. Neurosci"},{"key":"951_CR220","doi-asserted-by":"publisher","unstructured":"Zhao C, Tu J, Wang C, Liu W, Gu J, Yin Y, et al. Lysophosphatidylcholine binds \u03b1-synuclein and prevents its pathological aggregation. Natl Sci Rev. 2024;11(6):nwae182. https:\/\/doi.org\/10.1093\/nsr\/nwae182.","DOI":"10.1093\/nsr\/nwae182"},{"issue":"10","key":"951_CR221","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/molecules22101769","volume":"22","author":"J-H Hsiao","year":"2017","unstructured":"Hsiao J-H, Halliday GM, Kim WS. \u03b1-synuclein regulates neuronal cholesterol efflux. Molecules. 2017;22(10):22. https:\/\/doi.org\/10.3390\/molecules22101769.","journal-title":"Molecules"},{"issue":"1","key":"951_CR222","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1741-7015-5-20","volume":"5","author":"B Wolozin","year":"2007","unstructured":"Wolozin B, Wang SW, Li NC, Lee A, Lee TA, Kazis LE. Simvastatin is associated with a reduced incidence of dementia and Parkinson\u2019s disease. BMC Med. 2007;5(1):20. https:\/\/doi.org\/10.1186\/1741-7015-5-20.","journal-title":"BMC Med"},{"issue":"12","key":"951_CR223","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1001\/jamaneurol.2022.3718","volume":"79","author":"KN Stevens","year":"2022","unstructured":"Stevens KN, Creanor S, Jeffery A, Whone A, Zajicek J, Foggo A, et al. Evaluation of simvastatin as a disease-modifying treatment for patients with Parkinson disease: a randomized clinical trial. JAMA Neurol. 2022;79(12):1232\u201341. https:\/\/doi.org\/10.1001\/jamaneurol.2022.3718.","journal-title":"JAMA Neurol"},{"issue":"5","key":"951_CR224","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1111\/j.1471-4159.2008.05254.x","volume":"105","author":"P Bar-On","year":"2008","unstructured":"Bar-On P, Crews L, Koob AO, Mizuno H, Adame A, Spencer B, et al. Statins reduce neuronal \u03b1-synuclein aggregation in in vitro models of Parkinson\u2019s disease. J Neurochem. 2008;105(5):1656\u201367. https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05254.x.","journal-title":"J Neurochem"},{"issue":"43","key":"951_CR225","doi-asserted-by":"publisher","first-page":"13543","DOI":"10.1523\/JNEUROSCI.4144-09.2009","volume":"29","author":"A Ghosh","year":"2009","unstructured":"Ghosh A, Roy A, Matras J, Brahmachari S, Gendelman HE, Pahan K. Simvastatin inhibits the activation of p21 ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson\u2019s disease. J Neurosci. 2009;29(43):13543\u201356. https:\/\/doi.org\/10.1523\/JNEUROSCI.4144-09.2009.","journal-title":"J Neurosci"},{"issue":"3","key":"951_CR226","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s12640-017-9840-8","volume":"33","author":"NF Marques","year":"2018","unstructured":"Marques NF, Castro AA, Mancini G, Rocha FL, Santos ARS, Prediger RD, et al. Atorvastatin prevents early oxidative events and modulates inflammatory mediators in the striatum following intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in rats. Neurotox Res. 2018;33(3):549\u201359. https:\/\/doi.org\/10.1007\/s12640-017-9840-8.","journal-title":"Neurotox Res"},{"issue":"5","key":"951_CR227","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s12975-020-00883-0","volume":"12","author":"Y Yang","year":"2021","unstructured":"Yang Y, Yang LY, Salayandia VM, Thompson JF, Torbey M, Yang Y. Treatment with Atorvastatin during vascular remodeling promotes pericyte-mediated blood-brain barrier maturation following ischemic stroke. Transl Stroke Res. 2021;12(5):905\u201322. https:\/\/doi.org\/10.1007\/s12975-020-00883-0.","journal-title":"Transl Stroke Res"},{"issue":"7","key":"951_CR228","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/aps.2012.59","volume":"33","author":"Y Jin","year":"2012","unstructured":"Jin Y, Sui HJ, Dong Y, Ding Q, Qu WH, Yu SX, et al. Atorvastatin enhances neurite outgrowth in cortical neurons in vitro via up-regulating the Akt\/mTOR and Akt\/GSK-3\u03b2 signaling pathways. Acta Pharmacol Sin. 2012;33(7):861\u201372. https:\/\/doi.org\/10.1038\/aps.2012.59.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"951_CR229","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12974-023-02883-x","volume":"20","author":"EM Weekman","year":"2023","unstructured":"Weekman EM, Johnson SN, Rogers CB, Sudduth TL, Xie K, Qiao Q, et al. Atorvastatin rescues hyperhomocysteinemia-induced cognitive deficits and neuroinflammatory gene changes. J Neuroinflammation. 2023;20(1):199. https:\/\/doi.org\/10.1186\/s12974-023-02883-x.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"951_CR230","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40035-024-00398-w","volume":"13","author":"A Sharif","year":"2024","unstructured":"Sharif A, Mamo J, Lam V, Al-Salami H, Mooranian A, Watts GF, et al. The therapeutic potential of probucol and probucol analogues in neurodegenerative diseases. Transl Neurodegener. 2024;13(1):6. https:\/\/doi.org\/10.1186\/s40035-024-00398-w.","journal-title":"Transl Neurodegener"},{"issue":"3","key":"951_CR231","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s11064-012-0965-0","volume":"38","author":"RP Ribeiro","year":"2013","unstructured":"Ribeiro RP, Moreira ELG, Santos DB, Colle D, Dos Santos AA, Peres KC, et al. Probucol affords neuroprotection in a 6-OHDA mouse model of Parkinson\u2019s disease. Neurochem Res. 2013;38(3):660\u201368. https:\/\/doi.org\/10.1007\/s11064-012-0965-0.","journal-title":"Neurochem Res"},{"issue":"8","key":"951_CR232","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/aps.2016.51","volume":"37","author":"YS Jung","year":"2016","unstructured":"Jung YS, Park JH, Kim H, Kim SY, Hwang JY, Hong KW, et al. Probucol inhibits LPS-induced microglia activation and ameliorates brain ischemic injury in normal and hyperlipidemic mice. Acta Pharmacol Sin. 2016;37(8):1031\u201344. https:\/\/doi.org\/10.1038\/aps.2016.51.","journal-title":"Acta Pharmacol Sin"},{"issue":"6","key":"951_CR233","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1248\/bpb.b24-00099","volume":"47","author":"T Takeo","year":"2024","unstructured":"Takeo T, Miyake M, Mizuno H. Neuroprotective effects of probucol against rotenone-induced toxicity via suppression of reactive oxygen species production in SH-SY5Y cells. Biol Pharm Bull. 2024;47(6):1154\u201362. https:\/\/doi.org\/10.1248\/bpb.b24-00099.","journal-title":"Biol Pharm Bull"},{"issue":"9","key":"951_CR234","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.parkreldis.2009.03.002","volume":"15","author":"K Ono","year":"2009","unstructured":"Ono K, Ikemoto M, Kawarabayashi T, Ikeda M, Nishinakagawa T, Hosokawa M, et al. A chemical chaperone, sodium 4-phenylbutyric acid, attenuates the pathogenic potency in human \u03b1-synuclein A30P + A53T transgenic mice. Parkinsonism Relat Disord. 2009;15(9):649\u201354. https:\/\/doi.org\/10.1016\/j.parkreldis.2009.03.002.","journal-title":"Parkinsonism Relat Disord"},{"key":"951_CR235","doi-asserted-by":"publisher","unstructured":"Juarez D, Handal-Silva A, Mor\u00e1n-Perales JL, Torres-Cifuentes DM, Flores G, Trevi\u00f1o S, et al. New insights into sodium phenylbutyrate as a pharmacotherapeutic option for neurological disorders. Synapse. 2024;78(4):e22301. https:\/\/doi.org\/10.1002\/syn.22301.","DOI":"10.1002\/syn.22301"},{"key":"951_CR236","doi-asserted-by":"publisher","unstructured":"Roy A, Ghosh A, Jana A, Liu X, Brahmachari S, Gendelman HE, et al. Sodium phenylbutyrate controls neuroinflammatory and antioxidant activities and protects dopaminergic neurons in mouse models of Parkinson\u2019s disease. PLoS ONE. 2012;7(6):e38113. https:\/\/doi.org\/10.1371\/journal.pone.0038113.","DOI":"10.1371\/journal.pone.0038113"},{"key":"951_CR237","doi-asserted-by":"publisher","first-page":"112640","DOI":"10.1016\/j.intimp.2024.112640","volume":"138","author":"WH Elesawy","year":"2024","unstructured":"Elesawy WH, El-Sahar AE, Sayed RH, Ashour AM, Alsufyani SE, Arab HH, et al. Repurposing ezetimibe as a neuroprotective agent in a rotenone-induced Parkinson\u2019s disease model in rats: role of AMPK\/SIRT-1\/PGC-1\u03b1 signaling and autophagy. Int Immunopharmacol. 2024;138:112640. https:\/\/doi.org\/10.1016\/j.intimp.2024.112640.","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"951_CR238","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.cmet.2008.05.001","volume":"7","author":"TY Chang","year":"2008","unstructured":"Chang TY, Chang C. Ezetimibe blocks internalization of the NPC1L1\/cholesterol complex. Cell Metab. 2008;7(6):469\u201371. https:\/\/doi.org\/10.1016\/j.cmet.2008.05.001.","journal-title":"Cell Metab"},{"key":"951_CR239","doi-asserted-by":"publisher","first-page":"150116","DOI":"10.1016\/j.brainres.2025.150116","volume":"1873","author":"YH Hua","year":"2026","unstructured":"Hua YH, Huang XY, Ma JJ, Wu J, Zhou ZH. Ezetimibe mitigates microglial activation in Parkinson\u2019s disease via TLR4\/JNK pathway inhibition: evidence from network pharmacology and experimental validation. Brain Res. 2026;1873:150116. https:\/\/doi.org\/10.1016\/j.brainres.2025.150116.","journal-title":"Brain Res"},{"key":"951_CR240","doi-asserted-by":"publisher","first-page":"116442","DOI":"10.1016\/j.biopha.2024.116442","volume":"174","author":"JB Kim","year":"2024","unstructured":"Kim JB, Kim SJ, So M, Kim DK, Noh HR, Kim BJ, et al. Artificial intelligence-driven drug repositioning uncovers efavirenz as a modulator of \u03b1-synuclein propagation: implications in Parkinson\u2019s disease. Biomed Pharmacother. 2024;174:116442. https:\/\/doi.org\/10.1016\/j.biopha.2024.116442.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"951_CR241","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s13311-019-00731-6","volume":"16","author":"AM Petrov","year":"2019","unstructured":"Petrov AM, Pikuleva IA. Cholesterol 24-hydroxylation by CYP46A1: benefits of modulation for brain diseases. Neurotherapeutics. 2019;16(3):635\u201348. https:\/\/doi.org\/10.1007\/s13311-019-00731-6.","journal-title":"Neurotherapeutics"},{"issue":"32","key":"951_CR242","doi-asserted-by":"publisher","first-page":"13112","DOI":"10.1073\/pnas.1210833109","volume":"109","author":"YB Dai","year":"2012","unstructured":"Dai YB, Tan XJ, Wu WF, Warner M, Gustafsson J. Liver X receptor \u03b2 protects dopaminergic neurons in a mouse model of Parkinson disease. Proc Natl Acad Sci USA. 2012;109(32):13112\u201317. https:\/\/doi.org\/10.1073\/pnas.1210833109.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"951_CR243","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s12035-013-8461-3","volume":"48","author":"P Xu","year":"2013","unstructured":"Xu P, Li D, Tang X, Bao X, Huang J, Tang Y, et al. LXR agonists: new potential therapeutic drug for neurodegenerative diseases. Mol Neurobiol. 2013;48(3):715\u201328. https:\/\/doi.org\/10.1007\/s12035-013-8461-3.","journal-title":"Mol Neurobiol"},{"key":"951_CR244","doi-asserted-by":"publisher","first-page":"154125","DOI":"10.1016\/j.phymed.2022.154125","volume":"101","author":"JY Chen","year":"2022","unstructured":"Chen JY, Zhu Q, Cai CZ, Luo HB, Lu JH. \u03b1-mangostin derivative 4e as a PDE4 inhibitor promote proteasomal degradation of alpha-synuclein in Parkinson\u2019s disease models through PKA activation. Phytomedicine. 2022;101:154125. https:\/\/doi.org\/10.1016\/j.phymed.2022.154125.","journal-title":"Phytomedicine"},{"issue":"1","key":"951_CR245","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","volume":"10","author":"CA Ross","year":"2011","unstructured":"Ross CA, Tabrizi SJ. Huntington\u2019s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol. 2011;10(1):83\u201398. https:\/\/doi.org\/10.1016\/S1474-4422(10)70245-3.","journal-title":"The Lancet Neurol"},{"issue":"8","key":"951_CR246","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.bbalip.2014.12.018","volume":"1851","author":"V Leoni","year":"2015","unstructured":"Leoni V, Caccia C. The impairment of cholesterol metabolism in Huntington disease. Biochim Biophys Acta Mol Cell Biol Lipids. 2015;1851(8):1095\u2013105. https:\/\/doi.org\/10.1016\/j.bbalip.2014.12.018.","journal-title":"Biochim Biophys Acta (BBA) - Mol Cell Biol Lipids"},{"issue":"18","key":"951_CR247","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1093\/hmg\/ddm170","volume":"16","author":"M Valenza","year":"2007","unstructured":"Valenza M, Carroll JB, Leoni V, Bertram LN, Bj\u00f6rkhem I, Singaraja RR, et al. Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation. Hum Mol Genet. 2007;16(18):2187\u201398. https:\/\/doi.org\/10.1093\/hmg\/ddm170.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"951_CR248","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1515\/bmc-2015-0001","volume":"6","author":"JR Arndt","year":"2015","unstructured":"Arndt JR, Chaibva M, Legleiter J. The emerging role of the first 17 amino acids of huntingtin in Huntington\u2019s disease. Biomol Concepts. 2015;6(1):33\u201346. https:\/\/doi.org\/10.1515\/bmc-2015-0001.","journal-title":"Biomol Concepts"},{"issue":"43","key":"951_CR249","doi-asserted-by":"publisher","first-page":"36464","DOI":"10.1074\/jbc.M503672200","volume":"280","author":"KB Kegel","year":"2005","unstructured":"Kegel KB, Sapp E, Yoder J, Cuiffo B, Sobin L, Kim YJ, et al. Huntingtin associates with acidic phospholipids at the plasma membrane. J Biol Chem. 2005;280(43):36464\u201373. https:\/\/doi.org\/10.1074\/jbc.M503672200.","journal-title":"J Biol Chem"},{"issue":"21","key":"951_CR250","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1093\/hmg\/ddm217","volume":"16","author":"RS Atwal","year":"2007","unstructured":"Atwal RS, Xia J, Pinchev D, Taylor J, Epand RM, Truant R. Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity. Hum Mol Genet. 2007;16(21):2600\u201315. https:\/\/doi.org\/10.1093\/hmg\/ddm217.","journal-title":"Hum Mol Genet"},{"issue":"11","key":"951_CR251","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1523\/JNEUROSCI.0106-08.2008","volume":"28","author":"AL Orr","year":"2008","unstructured":"Orr AL, Li S, Wang CE, Li H, Wang J, Rong J, et al. N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking. J Neurosci. 2008;28(11):2783\u201392. https:\/\/doi.org\/10.1523\/JNEUROSCI.0106-08.2008.","journal-title":"J Neurosci"},{"key":"951_CR252","doi-asserted-by":"publisher","unstructured":"Stonebraker AR, Beasley M, Massinople S, Wunder M, Li P, Valentine SJ, et al. Cholesterol impacts the formation of huntingtin\/lipid complexes and subsequent aggregation. Protein Sci. 2023;32(5):e 4642. https:\/\/doi.org\/10.1002\/pro.4642.","DOI":"10.1002\/pro.4642"},{"key":"951_CR253","doi-asserted-by":"publisher","unstructured":"Birolini G, Valenza M, Di Paolo E, Vezzoli E, Talpo F, Maniezzi C, et al. Striatal infusion of cholesterol promotes dose-dependent behavioral benefits and exerts disease-modifying effects in Huntington\u2019s disease mice. EMBO Mol Med. 2020;12(10):e12519. https:\/\/doi.org\/10.15252\/emmm.202012519.","DOI":"10.15252\/emmm.202012519"},{"key":"951_CR254","doi-asserted-by":"publisher","first-page":"106823","DOI":"10.1016\/j.phrs.2023.106823","volume":"194","author":"G Birolini","year":"2023","unstructured":"Birolini G, Valenza M, Ottonelli I, Talpo F, Minoli L, Cappelleri A, et al. Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington\u2019s disease. Pharmacol Res. 2023;194:106823. https:\/\/doi.org\/10.1016\/j.phrs.2023.106823.","journal-title":"Pharmacological Res"},{"issue":"8","key":"951_CR255","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1093\/brain\/awz174","volume":"142","author":"R Kacher","year":"2019","unstructured":"Kacher R, Lamazi\u00e8re A, Heck N, Kappes V, Mounier C, Despres G, et al. CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington\u2019s disease. Brain. 2019;142(8):2432\u201350. https:\/\/doi.org\/10.1093\/brain\/awz174.","journal-title":"Brain"},{"issue":"5","key":"951_CR256","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/nn.2528","volume":"13","author":"M Martinez-Vicente","year":"2010","unstructured":"Martinez-Vicente M, Talloczy Z, Wong E, Tang G, Koga H, Kaushik S, et al. Cargo recognition failure is responsible for inefficient autophagy in Huntington\u2019s disease. Nat Neurosci. 2010;13(5):567\u201376. https:\/\/doi.org\/10.1038\/nn.2528.","journal-title":"Nat. Neurosci"},{"issue":"1","key":"951_CR257","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3233\/JHD-150181","volume":"5","author":"JY Chen","year":"2016","unstructured":"Chen JY, Tran C, Hwang L, Deng G, Jung ME, Faull KF, et al. Partial amelioration of peripheral and central symptoms of Huntington\u2019s disease via modulation of lipid metabolism. J Huntingtons Dis. 2016;5(1):65\u201381. https:\/\/doi.org\/10.3233\/JHD-150181.","journal-title":"J Huntingtons Dis"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-026-00951-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-026-00951-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-026-00951-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T01:14:15Z","timestamp":1785114855000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13024-026-00951-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":257,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["951"],"URL":"https:\/\/doi.org\/10.1186\/s13024-026-00951-3","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read and approved the final version of the manuscript and consent to its publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"40"}}